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ABSTRACT
MITOCHONDRIAL REGULATION OF YEAST AMPK DURING ENERGY STRESS
by
Aishwarya Shevade
The University of Wisconsin-Milwaukee, 2017
Under the Supervision of Dr. Sergei Kuchin
In eukaryotes, members of the conserved AMP-activated protein kinase (AMPK) family
play a pivotal role in sensing and responding to energy stress. Mammalian AMPK becomes
activated when the AMP:ATP ratio is too high, and functions to prevent unnecessary ATP
spending and to increase ATP production. Due to their role in ATP production through aerobic
respiration, mitochondria are known to play an indirect role in the negative control of AMPK.
The conserved voltage-dependent anion channel (VDAC) proteins, also known as mitochondrial
porins, mediate the passage of small metabolites between the mitochondria and cytoplasm,
including the release of ATP. One would therefore expect VDACs to play a role in the negative
regulation of AMPK. Contrary to this expectation, our results in budding yeast (Saccharomyces
cerevisiae) provide evidence that mitochondria and VDACs play a role in the positive control of
Snf1, the yeast homolog of AMPK.
In yeast, Snf1 protein kinase stimulates the utilization of alternate carbon/energy sources
when the preferred source – glucose – becomes limiting. Under carbon/energy stress conditions,
Snf1 is activated and enriches in the nucleus to elicit various transcriptional responses.
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Our results indicate that Snf1 physically interacts with the yeast VDAC proteins Por1 and
Por2. Interestingly, Por1 and Por2 contribute to the positive - rather than negative - control of
Snf1. We present evidence indicating that Por1 and Por2 function redundantly to promote Snf1
catalytic activation, presumably as receptors of an intracellular glucose/energy signal. We also
present evidence for novel mechanisms by which mitochondria positively regulate Snf1 nuclear
localization.
In summary, our experiments in yeast reveal an array of mechanisms by which
mitochondria positively regulate Snf1/AMPK, i.e. in a way that would be entirely counterintuitive to researchers in the mammalian field. Due to the evolutionary conservation of the
players involved, further studies of these novel mechanisms in the yeast model could provide
invaluable insights into the etiology and therapy of AMPK- ,VDAC-, and mitochondriaassociated diseases including cancer, diabetes, obesity, and cardiac disorders.
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Chapter 1
Introduction
Overview
Eukaryotic cells prefer glucose as their carbon and energy source. Glucose starvation creates
energy stress. Cells have developed mechanisms to sense and cope with such a critical stress, and
carefully turn on their energy-conservation mode under glucose-limiting conditions. Cells can
pick up cues from outside and from within, such as from the mitochondria, the “powerhouse of
the cell”, to determine the energy status and mount an appropriate response. The highly
conserved Snf1/AMPK stress response pathway regulates the energy levels of eukaryotic cells
from yeast to humans.

AMP-activated protein kinase
AMP – activated protein kinase (AMPK) is the key regulator of many metabolic
processes in humans and is widely known for its effects on metabolism and regulation of cell
growth and proliferation (HARDIE 2011a; HARDIE et al. 2012b). AMPK monitors levels of
energy nucleotides such as ATP, ADP, and AMP. During metabolic stresses such as
hypoglycemia, exercise, and hypoxia AMPK is activated by sensing the AMP:ATP ratio (and
also ADP:ATP ratio), and hence is aptly referred to as the “fuel gauge” of the cell (HARDIE et al.
1998). AMPK maintains energy equilibrium by balancing energy-consuming and energygenerating processes (Fig. 1). AMPK stimulates processes such as glucose uptake, glycolysis,
fatty acid uptake and fatty acid oxidation, and mitochondrial biogenesis that generate more ATP
(HARDIE 2008; HARDIE 2011a). At the same time, active AMPK inhibits anabolic pathways such
as fatty acid synthesis, glycogen synthesis and gluconeogenesis, thus reducing energy
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expenditure (HARDIE 2008; HARDIE 2011b). AMPK performs its function by phosphorylating
key enzymes in these pathways, which are sensitive to energy levels, and by regulating the
expression of various genes (HARDIE et al. 1998; HARDIE 2011a; HARDIE et al. 2012b).
Energy-depleting stress conditions
(e.g. exercise, hypoglycemia, hypoxia, etc.)

Increased
AMP-to-ATP ratios

AMPK

Reduced ATP consumption

Increased ATP generation

(e.g. slower cell growth)

(e.g. increased glucose uptake,
mitochondrial biogenesis, etc.)

Fig. 1. Role of AMP-activated protein kinase (AMPK) in maintaining energy equilibrium. AMPK senses

Fig. 1. Role depleting
of AMP-activated
protein
kinase
(AMPK) in
maintaining
energy equilibrium.
depleting
energy reserves
(high
AMP/ADP:ATP
ratio)
and gets activated.
Active AMPK AMPK
respondssenses
to
energy stress by stimulating catabolic ATP-generating processes and inhibiting anabolic ATP-consuming
processes.
Adapted from
Barrett
energy reserves
(high AMP:ATP
ratio)
and2011.
gets activated. Active AMPK responds to energy stress by stimulating

catabolic ATP-generating processes and inhibiting anabolic ATP-consuming processes. Adapted from (BARRETT
2011).

Structure and regulation of AMPK
AMPK is a heterotrimeric protein complex consisting of the catalytic α subunit,
regulatory β subunit, and sensory γ subunit (HARDIE 2011a; HARDIE 2011b; HARDIE et al.
2012b) (Fig. 2). There are multiple isoforms of these subunits in mammals, making for twelve
combinations of heterotrimers. Present at the N terminus of the α subunit is the protein kinase
domain containing the conserved threonine (Thr172) in the activation loop, whose
phosphorylation by upstream kinases results in AMPK activation (see below) (HAWLEY et al.
1996). The kinase domain is followed by the auto-inhibitory domain (AID) that is connected to
the C-terminal domain of the catalytic subunit (α-CTD) by a linker peptide. AID keeps the
2

kinase domain inactive and lowers kinase activity in non-stressful conditions (PANG et al. 2007).
The C- terminal domain of the β subunit (β-CTD)

α Subunits
N

P

Thr-172

Kinase Domain

AID

β Subunits
Glycogen binding

Linker

C

α binding

CBM

N

α-CTD

β-CTD

C

γ binding

γ Subunits
N

Adenine nucleotide binding

CBS1

CBS2

CBS3

CBS4

C

Fig. 2. Structure of AMPK. AMPK is a heterotrimer of α, β, γ subunits. The catalytic α subunit contains
Fig. 2. Structure
of the
AMPK.
AMPK
is a that
heterotrimer
of α,by
β, and
γ subunits. Thewhich
catalytic
α subunit contains
Thr172
Thr172 in
kinase
domain
is activated
phosphorylation,
is otherwise
protected
by
autoinhibitory domain (AID). The regulatory β subunit binds to α and γ subunits via its C-terminus. γ
in the kinase
domain
is activated
by phosphorylation,
whichthe
is otherwise
by autoinhibitory
domain
subunit
actsthat
as the
sensor that
binds to AMP when
AMP:ATPprotected
ratio is high
under low glucose
conditions. Adapted from Hardie, et al. 2012.
(AID). The regulatory β subunit binds to α and γ subunits via its C terminus. γ subunit acts as the sensor that binds

to AMP when the AMP:ATP ratio is high under low glucose conditions. Adapted from (HARDIE et al. 2012a).

binds to α-CTD and the γ subunit, thus holding the heterotrimeric complex together. There are
carbohydrate-binding modules (CBM) in the β subunits that possibly allow AMPK to sense
energy reserves in the form of glycogen levels (POLEKHINA et al. 2003). Such CBMs present in
enzymes, such as glycogen synthase, help in the co-localization of AMPK and its downstream
targets bound to glycogen. The γ subunit of AMPK contains four cystathione β synthase (CBS)
repeats that bind to adenine nucleotides (KEMP 2004; SCOTT et al. 2004). AMP and ATP bind to
3

two sites in the γ subunit causing opposite effects (OAKHILL et al. 2011; XIAO et al. 2011).
AMPK senses increased AMP:ATP ratio during low energy conditions, and AMP binds to the γ
subunit changing the conformation of AMPK and releasing autoinhibition, allowing activation of
AMPK by phosphorylation of the Thr172 residue in the kinase domain of the α subunit
(HAWLEY et al. 1996; HARDIE AND HAWLEY 2001). Moreover, AMP binding protects AMPK
from dephosphorylation by phosphatases (DAVIES et al. 1995; SUTER et al. 2006); it has also
been shown that β subunit myristoylation is a prerequisite for Thr172 phosphorylation (OAKHILL
et al. 2010).
Together, the binding of AMP (at the exclusion of ATP) to the γ subunit and subsequent
phosphorylation of Thr172 lead to a more than 1000-fold activation of AMPK (Fig. 3) (HARDIE
2011b). During conditions that correspond to low energy (high AMP:ATP), such as
hypoglycemia and hypoxia, and metabolic stresses that increase ATP consumption, AMPK is
activated by upstream kinase liver kinase B1 (LKB1) (HAWLEY et al. 2003; HONG et al. 2003;
WOODS et al. 2003). Apart from LKB1, which is the major upstream kinase, AMPK can also be
activated by Ca2+/calmodulin-dependent kinase kinase β (CaMKKβ) in response to a rise in Ca2+
levels that is normally associated with ATP-consuming processes such as contraction of skeletal
muscles (HAWLEY et al. 2005; HONG et al. 2005; WOODS et al. 2005). Evidence suggests that
toxic reactive oxygen species (ROS) such as hydrogen peroxide H2O2, and xenobiotic
compounds such as metformin, a drug commonly used for treating type 2 diabetes, also activate
AMPK (HAWLEY et al. 2010). The upstream kinases may continually phosphorylate AMPK, but
in the absence of metabolic stresses, removal of the phosphate group by phosphatases such as
protein phosphatase 2C (PP2C), and protein phosphatase 1 (PP1), will maintain the inactive state
of AMPK (DAVIES et al. 1995; GARCIA-HARO et al. 2010).
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Inactive

γ
ATP

β

KD

α

P

KD

Active

γ

AMP

β

α

Fig. 3. A simplified diagram of AMPK regulation. Top panel shows AMPK in its inactive conformation. Under low
energy conditions, AMP binds to the γ subunit creating a conformational change in AMPK, and activation-loop
Thr172 is phosphorylated (bottom panel). KD, kinase domain. Adapted from (BARRETT 2011).

Downstream targets of AMPK
Active AMPK phosphorylates downstream targets at Ser/Thr residues to turn on energygenerating catabolic pathways and turn off energy-consuming anabolic pathways (HARDIE et al.
2012b; HARDIE et al. 2016). AMPK promotes glucose and fatty acid uptake in the cells by
increased translocation of transporters GLUT1 and CD36, respectively, to the plasma membrane
(BARNES et al. 2002; HABETS et al. 2009). Subsequently, by phosphorylating rate-limiting
enzymes, AMPK stimulates glycolysis, mitochondrial respiration and fatty acid oxidation
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(MERRILL et al. 1997; WINDER et al. 2000). Mitochondrial biogenesis and maintenance of
healthy mitochondria is also regulated by AMPK, ultimately leading to increased breakdown of
glucose and fatty acids (EGAN et al. 2011; O'NEILL et al. 2011) (O’Neill 2011; Egan et al 2011).
On the other hand, AMPK downregulates anabolic processes by phosphorylating proteins and
enzymes in fatty acid, glycogen, and protein biosynthesis pathways (reviewed in (HARDIE et al.
2012b)). AMPK achieves energy conservation by slowing down cell growth and proliferation,
thus exerting its anti-tumor effects (HAWLEY et al. 2003).
Due to its central role in maintaining energy homeostasis, AMPK is a therapeutic target
for type 2 diabetes and many other conditions such as obesity, cardiovascular disorders, and
cancer (HARDIE 2007; FOGARTY AND HARDIE 2009; OAKHILL et al. 2011). Although much is
known about the structure, function, and regulation of AMPK, a detailed understanding of these
areas needs further investigation. AMPK structure and function are conserved across different
species. Saccharomyces cerevisiae serves as an important model organism to study most aspects
of AMPK.

Yeast as a model organism
Saccharomyces cerevisiae, commonly known as baker’s yeast (brewer’s yeast, or
budding yeast), is a simple eukaryote that nonetheless shares many genes with humans. Yeast
cells are easy to propagate, and – importantly – this organism has a sexual haploid-diploid life
cycle, making it easy to make combinatorial mutants. Interestingly, yeast cells have the capacity
to survive without mitochondrial respiration, facilitating the analysis of mutants with
mitochondrial defects, which is highly relevant to this work.
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Snf1 protein kinase
Snf1, the yeast homolog of AMPK, is a founding member of the Snf1/AMPK family of
serine/threonine protein kinases (HARDIE et al. 1998). Yeast cells prefer glucose as their
carbon/energy source. Snf1, like AMPK, plays important roles in the metabolic control during
nutrient stress, especially glucose limitation (HEDBACKER AND CARLSON 2008). Snf1 activates
catabolic processes and inhibits anabolic processes whenever yeast cells are starved for glucose
(HEDBACKER AND CARLSON 2008). Active Snf1 switches on the transcription of genes required
for the utilization of less preferred sugars such as sucrose, galactose, raffinose, etc. (CARLSON et
al. 1981; CELENZA AND CARLSON 1986; TREITEL et al. 1998). In fact, Snf1 was identified in a
screen for mutants that are unable to utilize sucrose, giving Snf1 its name, sucrose nonfermenting 1 (CARLSON et al. 1981). Moreover, Snf1 is essential to turn on mitochondrial
respiration and utilize non-fermentable carbon sources such as glycerol and ethanol (CELENZA
AND CARLSON

1984).

Glucose limitation

Snf1

Slower growth

Utilization of less preferred
carbon/energy sources
( e.g. sucrose, glycerol)

Fig. 4. AMPK of yeast cells: Snf1. Snf1 plays a central role in adaptation of yeast cells to nutrient
stressesofsuch
low glucose,
by plays
slowing
down cell
and utilizing
alternative
carbon sources.
Fig. 4. AMPK
yeastascells:
Snf1. Snf1
a central
rolegrowth
in adaptation
of yeast
cells to nutrient
stresses such as
Adapted from Barrett 2011.

low glucose, by slowing down cell growth and utilizing alternative carbon sources. Adapted from (BARRETT 2011).

7

Structure of Snf1
Snf1 protein kinase is a heterotrimeric protein consisting of the catalytic α subunit Snf1,
three alternative regulatory β subunits, Gal83, Sip1 and Sip2, and the γ subunit Snf4
(HEDBACKER AND CARLSON 2008). The Snf1 catalytic subunit contains a kinase domain at the N
terminus, and a regulatory domain at the C terminus (CELENZA AND CARLSON 1986; ESTRUCH et
al. 1992). The kinase domain contains the activation loop Thr210 residue (equivalent to Thr172
of AMPK) that is phosphorylated by upstream kinases to activate Snf1 (CELENZA AND CARLSON
1986; ESTRUCH et al. 1992; MCCARTNEY AND SCHMIDT 2001; HONG et al. 2003; NATH et al.
2003; SUTHERLAND et al. 2003). Crystal structure analyses suggest that the kinase domain forms
homodimers, and in the inactive state the activation loop is buried within the dimers;
interestingly, the kinase domain itself can be phosphorylated and regulated, bypassing the need
for regulation by β and γ subunits (RUDOLPH et al. 2005; NAYAK et al. 2006). The C terminus
contains the autoinhibitory sequence (AIS), which binds to the kinase domain as well as γ
subunit Snf4. Deletion of the AIS region alleviates the requirement for Snf4 (CELENZA AND
CARLSON 1989; ESTRUCH et al. 1992; JIANG AND CARLSON 1996). AIS binds to the kinase
domain and inhibits its activation; however, under glucose limiting conditions, Snf4 binds to AIS
and releases the inhibition allowing Snf1 activation (CELENZA AND CARLSON 1989; ESTRUCH et
al. 1992; JIANG AND CARLSON 1996; LEECH et al. 2003). The C terminus also contains a region
that binds to the β subunits (JIANG AND CARLSON 1997).
There are three alternative β subunits: Gal83, Sip1, and Sip2, forming three possible Snf1
protein kinase complexes (YANG et al. 1994; SCHMIDT AND MCCARTNEY 2000). The β subunits
are responsible for unique subcellular localization of Snf1 (VINCENT et al. 2001) (Fig. 5). This is
achieved by the presence of divergent N termini in the β subunits. All three Snf1 complexes are
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cytoplasmic when abundant glucose is available. However, under metabolic stress such as
glucose limitation, redistribution of Snf1 complexes occurs depending on the β subunit: Gal83
enriches in the nucleus, Sip1 relocalizes to the vacuole, and Sip2 remains cytoplasmic (VINCENT
et al. 2001). The C terminus of the β subunits has a conserved sequence that mediates their
interaction with Snf1 and Snf4 (YANG et al. 1994; JIANG AND CARLSON 1997). The C terminus
also contains a glycogen-binding domain (GBD), similar to CBM of the β subunits in AMPK.
The Snf1-Gal83 complex is the major isoform observed during growth on glucose and
contributes the most in response to glucose limitation (HEDBACKER et al. 2004). Levels of Sip2
appear to somewhat increase when cells are shifted to non-fermentable carbon sources, whereas
Sip1 levels remain constant (VINCENT et al. 2001).

Upstream Kinases

β

P
Snf1

Low Glucose

Snf4

Gal83

P
Snf1
P
Snf1

Nucleus

Snf4
Sip2

P
Vacuole

Fig. 5. Snf1
Sip2), and γ

Snf4

Sip1

Snf1

Snf4

Fig. 5. Snf1 structure and regulation. Snf1 protein kinase is a heterotrimer consisting of α (Snf1), β
(Gal83, Sip1, Sip2), and γ (Snf4) subunits. The catalytic α subunit, Snf1, contains a conserved activationloop
Thr-210
in its kinase
domain,
whichkinase
is phosphorylated
by upstreamconsisting
kinases in response
to low β (Gal83, Sip1,
structure
and
regulation.
Snf1
protein
is a heterotrimer
of α (Snf1),
glucose. Snf1 complex is cytoplasmic when abundant glucose is available. However, under glucose
limitation, Gal83 relocates active Snf1 to the nucleus, Sip1 takes Snf1 to vacuolar membrane, and the
(Snf4) subunits.
The catalytic
α subunit,
Snf1,
contains
a conserved
activation-loop
Thr-210 in its
complex containing
Sip2 remains
cytoplasmic.
Adapted
from Headbacker
and Carlson
2008.

kinase domain, which is phosphorylated by upstream kinases in response to low glucose. Snf1 complex is
cytoplasmic when abundant glucose is available. However, under glucose limitation, Gal83 relocates active Snf1 to
the nucleus, Sip1 takes Snf1 to the vacuolar membrane, and the complex containing Sip2 remains cytoplasmic.
Adapted from (HEDBACKER AND CARLSON 2008).

9

The γ subunit, Snf4, binds to Snf1 and the different β subunits. Binding of Snf4 to AIS prevents
AIS binding to the kinase domain of Snf1, thus allowing activation of Snf1 by upstream kinases
(CELENZA AND CARLSON 1989; ESTRUCH et al. 1992; JIANG AND CARLSON 1996; LEECH et al.
2003). Snf4 contains four CBS repeats that are known to bind to adenine nucleotides (BATEMAN
1997). However, unlike γ subunits of AMPK, which bind to AMP and act as sensors of energy
stress, Snf4 is not known to bind to AMP to allosterically activate Snf1 (MITCHELHILL et al.
1994; WILSON et al. 1996; ADAMS et al. 2004). Instead, in vitro studies suggest that although
AMP, ADP, and ATP bind to Snf4, Snf4 bound to ADP (not AMP) protects it from
dephosphorylation by phosphatases, thus maintaining the Thr210 residue in the phosphorylated
state (CHANDRASHEKARAPPA et al. 2011; MAYER et al. 2011).

Regulation of Snf1
Snf1 activation is regulated by glucose availability. Sak1, Tos3, and Elm3 are three
upstream kinases that activate Snf1 by phosphorylation of Thr210 in the activation loop during
glucose limitation, as well as other environmental stresses including alkaline pH, salt stress, and
oxidative stress (HONG et al. 2003; NATH et al. 2003; SUTHERLAND et al. 2003; HONG AND
CARLSON 2007). While all three kinases have overlapping functions, Sak1 is the major kinase
that activates Snf1; however, to observe a Snf1 null phenotype, all three kinases have to be
deleted (HONG et al. 2003; NATH et al. 2003; SUTHERLAND et al. 2003). Sak1 is not only
important for activating Snf1, but also necessary and sufficient for nuclear localization of the
Snf1-Gal83 complex, while Elm1 and Tos3 do not seem to play a major role (HEDBACKER et al.
2004).
Snf1 is inactivated by Thr210 dephosphorylation, which primarily involves type 1 protein
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phosphatase Glc7 in association with a regulatory protein Reg1 (TU AND CARLSON 1994; TU AND
CARLSON 1995; MCCARTNEY AND SCHMIDT 2001). In cells lacking Reg1, Snf1 is constitutively
switched on during growth on high glucose (MCCARTNEY AND SCHMIDT 2001). Reg2, another
targeting subunit of Glc7, contributes to dephosphorylation of Snf1 when cells are replenished
with glucose after prolonged starvation (FREDERICK AND TATCHELL 1996; MAZIARZ et al. 2016).
Apart from Glc7, other phosphatases including Sit4, a type 2A-like protein phosphatase, and
Ptc1, a type 2C protein phosphatase, have been implicated in dephosphorylation and inactivation
of Snf1 (RUIZ et al. 2011; RUIZ et al. 2013).
Recent evidence also suggests that ubiquitination (WILSON et al. 2011) and SUMOylation
(SIMPSON-LAVY AND JOHNSTON 2013) affect Snf1 Thr210 phosphorylation and activity. While
the identity of the kinases and phosphatases that regulate Snf1 has been established, the
mechanisms that regulate the balance between Thr210 phosphorylation and dephosphorylation
are not completely understood and need further investigation.

Downstream targets of Snf1
Snf1 is critical for yeast cells to respond to energy stress such as glucose limitation. To
achieve this, active Snf1 regulates transcription of various genes by phosphorylating repressors
and activators and modifies enzymatic activity by phosphorylating enzymes of rate-limiting steps
(HARDY et al. 1994; WOODS et al. 1994; HUANG et al. 1996; RANDEZ-GIL et al. 1997; TREITEL et
al. 1998). In the end, Snf1 maintains energy homeostasis by activating genes that help the cells
utilize alternative carbon sources, promotes respiration, inhibits energy-consuming synthesis of
large polymers such as fatty acids, and slows down cell growth (HEDBACKER AND CARLSON
2008).
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Snf1 regulates gene expression by phosphorylating transcription factors such as the Mig1
repressor (OSTLING AND RONNE 1998; TREITEL et al. 1998). Inactivation of Mig1 leads to the
release of Mig1-dependent repression of many genes including SUC, GAL, MAL, and other
glucose-repressible genes whose expression is inhibited by Mig1 in high glucose (TREITEL AND
CARLSON 1995; TZAMARIAS AND STRUHL 1995). Snf1 also regulates transcriptional activators
such as Cat8, which is phosphorylated by Snf1 directly (RANDEZ-GIL et al. 1997). Cat8 is
responsible for activating transcription (de-repression) of gluconeogenic genes and for growth on
non-fermentable carbon sources (RANDEZ-GIL et al. 1997; YOUNG et al. 2003). Snf1 turns on
mitochondrial respiration, and the snf1∆ mutant is unable to grow on non-fermentable carbon
sources such as ethanol and glycerol. It is known that transcription of many genes involved in
the mitochondrial transport of metabolites is Snf1 dependent (YOUNG et al. 2003). Evidence also
suggests that Snf1 modifies histone H3 by phosphorylation, regulates histone acetylation, and
affects global gene expression (LO et al. 2000; ZHANG et al. 2013).
Snf1 also regulates activity of many enzymes involved in metabolic pathways by direct
phosphorylation. For example, active Snf1 phosphorylates acetyl-CoA carboxylase (Acc1) and
inhibits fatty acid biosynthesis to save energy expenditure (WOODS et al. 1994). Additionally,
Snf1 regulates the activity of glycogen synthase responsible for the rate-limiting step in
accumulation of glycogen in cells (HARDY et al. 1994; HUANG et al. 1996).
Apart from responding to energy stress, Snf1 is activated in response to environmental
stresses such as nitrogen limitation, sodium and lithium ion stress, pH stress, and oxidative stress
(ORLOVA et al. 2006; HONG AND CARLSON 2007). Activated Snf1 enriches in the nucleus in
response to some stresses, such as glucose limitation and alkaline pH, but not others such as salt
stress (HONG AND CARLSON 2007).
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Comparison of Snf1 and AMPK
Snf1 and AMPK are highly conserved in their structure, regulation, and function (HARDIE
et al. 1998; HEDBACKER AND CARLSON 2008; GHILLEBERT et al. 2011). Snf1 and AMPK turn on
ATP-generating catabolic processes and turn off ATP-consuming anabolic process during
nutrient stress. Snf1 and AMPK regulate transcription of genes and activity of metabolic
enzymes by phosphorylation. Activation of these signaling kinases stimulates respiration that
leads to increased energy production.
Snf1 and AMPK are heterotrimers each consisting of a catalytic α subunit and regulatory
β and γ subunits (GHILLEBERT et al. 2011). The kinase domain of the α subunit contains a
conserved activation loop threonine that is phosphorylated by upstream kinases for activation of
Snf1/AMPK signaling. The β subunits act as scaffolding proteins that hold together the
heterotrimer, and the γ subunits have the CBS domains that bind to different adenine nucleotides.
The regulation of Snf1/AMPK by phosphorylation and dephosphorylation is also very
conserved. As a matter of fact, establishing the identity of the kinases that activate Snf1 in yeast
facilitated the discovery of mammalian kinases that phosphorylate and activate AMPK (HONG et
al. 2003; MOMCILOVIC et al. 2006). Yeast Snf1 upstream kinases such as Tos3 can activate
mammalian AMPK in vitro (HONG et al. 2003). Similarly, the AMPK-activating kinases, LKB1
and CaMKKβ, can activate Snf1 in yeast (HONG et al. 2005; MOMCILOVIC et al. 2006). AMP, a
signal of low energy, binds to the γ subunit of AMPK (at the exclusion of ATP) and creates a
conformational change that leads to allosteric activation of AMPK; AMP binding makes AMPK
a better substrate for activation by upstream kinases and protects AMPK from dephosphorylation
(HARDIE 2011b). Unlike with AMPK, however, AMP does not allosterically activate Snf1 and
the signal that leads to activation of Snf1 remains elusive (HARDIE et al. 1998). It has been
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shown that ADP binds to Snf4 and protects Snf1 from dephosphorylation in vitro (MAYER et al.
2011). However, based on analysis of ADP and ATP binding affinities, it was suggested that the
yeast Snf1 complex responds to absolute ADP levels rather than to ADP:ATP ratios (MAYER et
al. 2011). According to an earlier report, however, the absolute ADP levels in yeast cells shifted
from high to low glucose do not appear to change as much as the AMP:ATP or ADP:ATP ratios
(WILSON et al. 1996). In other words, whether absolute ADP levels represent a true in-vivo signal
for Snf1 activation remains an open question, and the existence of additional mechanisms that
could regulate Snf1 in response to AMP:ATP ratios remains a distinct possibility.
In an attempt to identify new regulators of Snf1, a yeast two-hybrid screen was
performed, recovering a novel Snf1-interacting partner: the mitochondrial voltage-dependent
anion channel yVDAC1/Por1 (VYAS et al. 2001).

Voltage-dependent anion channels
Voltage-dependent anion channel (VDAC) proteins, also called mitochondrial porins, are
conserved proteins present in the outer membrane of mitochondria and allow passage of small
metabolites including AMP, ADP, and ATP (COLOMBINI 2004; COLOMBINI AND MANNELLA
2012). As the name suggests, VDACs are voltage-gated and, depending on the potential applied,
VDACs can exist in two states: open and closed (PENG et al. 1992; COLOMBINI 2004;
COLOMBINI AND MANNELLA 2012). In their open state, VDACs prefer anions including adenine
nucleotides and metabolites of the TCA cycle. In their closed state, cations such as Ca2+ can be
transported in and out of mitochondria. VDACs are not only important for metabolic flux
between cytoplasm and mitochondria, but they are also involved in respiration, apoptosis, and
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cancer (COLOMBINI 2004; LEMASTERS AND HOLMUHAMEDOV 2006; SHOSHAN-BARMATZ AND
BEN-HAIL 2011).
The structure of VDACs is conserved across eukaryotes (Fig. 6); VDACs are β barrel
proteins containing ~12-19 β strands embedded in the membrane with hydrophobic residues
exposed to the lipid bilayer and hydrophilic residues forming the core with a diameter of ~3nm.
VDACs also
contain an α helix
at the N terminus,
is important
metabolite
selectivity
VDAC1_YEAST
; Mitochondrial
outer which
membrane
proteinforporin
1; Voltage-dependent
anion-selective channel protein 1; VDAC-1; Saccharomyces cerevisiae (strain ATCC
(PENG et al.
1992; Z
2010).
204508
/ ETH
S288c)
(Baker's yeast).
A

B

Fig. 6. Structure of yVDAC1. (A) Side view. (B) Top view. Source: http://www.uniprot.org/uniprot/P04840

In humans, there are three VDACs that show
tissue specific expression and function
Residue'range:'3.283'
(SHOSHAN-BARMATZ AND BEN-HAIL 2011). Yeast cells express two VDAC isoforms, yVDAC1
and yVDAC2 (also called Por1 and Por2, respectively). Por1 is an abundant 283 amino-acid
protein in the mitochondrial outer membrane (MOM) and its permeability has been studied over
many years (COLOMBINI 2004). Por2 is 49% identical to Por1 and localizes to the MOM, but is
not believed to have channel function (BLACHLY-DYSON et al. 1997; LEE et al. 1998).
Based on the preliminary interaction between Snf1 and Por1, and the functional
involvement of the porins with adenine nucleotides, we hypothesized that Por1 and Por2 may be

15

involved in the regulation of Snf1. This work primarily aims at elucidating the mechanisms by
which mitochondria communicate with the Snf1 signaling pathway via porins.
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Chapter 2
Mitochondrial porin Por1 and its homolog Por2 contribute to the positive control of Snf1
protein kinase in Saccharomyces cerevisiae
[The results presented in this chapter have been published (STROGOLOVA et al. 2012)]
Abstract
Saccharomyces cerevisiae Snf1 is a member of the conserved Snf1/AMP-activated protein
kinase (Snf1/AMPK) family involved in regulating responses to energy limitation, which is
detected by mechanisms that include sensing adenine nucleotides. Mitochondrial voltagedependent anion channel (VDAC) proteins, also known as mitochondrial porins, are conserved in
eukaryotes from yeast to humans and play key roles in mediating mitochondrial outer membrane
permeability to small metabolites including ATP, ADP, and AMP. We previously recovered the
yeast mitochondrial porin Por1 (yVDAC1) from a two-hybrid screen for Snf1-interacting
proteins. Here, we present evidence that Snf1 interacts with Por1 and its homolog Por2
(yVDAC2). Cells lacking Por1 and Por2, but not respiratory-deficient rho0 cells lacking the
mitochondrial genome, exhibit reduced Snf1 activation-loop phosphorylation in response to
glucose limitation. Thus, Por1 and Por2 contribute to the positive control of Snf1 protein kinase.
Physical proximity to the VDAC proteins and mitochondrial surface could facilitate Snf1’s
ability to sense energy limitation.

Introduction
Mammalian AMP-activated protein kinase (AMPK) is often referred to as the cell’s “fuel
gauge” (HARDIE AND CARLING 1997). According to the standard model, AMPK responds to
decreases in cellular energy by sensing increased levels of AMP relative to ATP (HARDIE 2007c;
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HARDIE 2007b). The AMPK activation mechanism involves AMP binding to the γ subunit of the
AMPK complex at the exclusion of ATP, making the catalytic α subunit of AMPK a better
substrate for activation-loop threonine (Thr172) phosphorylation by upstream kinases while
interfering with its dephosphorylation and inactivation. More recent evidence indicates that
besides AMP binding, ADP binding also stimulates Thr172 phosphorylation of AMPK and
protects it from dephosphorylation (OAKHILL et al. 2011; XIAO et al. 2011). Activated AMPK
functions to balance the energy “budget” by cutting general energy spending (e.g. by inhibiting
cell growth and proliferation) while activating specific energy-generating mechanisms (e.g.
glucose uptake). In accord with these important roles, defects in AMPK signaling have been
linked to diabetes, obesity, and cancer, making AMPK a good drug target (HARDIE 2007a;
FOGARTY AND HARDIE 2009).
Decreases in cellular energy levels can be caused by factors ranging from reduced
glucose availability to reduced mitochondrial respiration (KAHN et al. 2005). Metformin, a drug
that is often prescribed to patients with type 2 diabetes, is thought to activate AMPK indirectly,
by affecting the respiratory complex chain I (EL-MIR et al. 2000; BRUNMAIR et al. 2004).
Metformin also exhibits anti-cancer action, an effect that is largely mediated by AMPK
(VAKANA AND PLATANIAS 2011; DOWLING et al. 2012). These findings indicate that a better
understanding of the functional connection between AMPK and mitochondria could provide
valuable clues to the molecular etiology, treatment, and prevention of metabolic disorders and
cancer.
Snf1 protein kinase of the yeast Saccharomyces cerevisiae is the homolog of mammalian
AMPK and is required for growth on carbon sources that are less preferred than glucose,
including non-fermentable carbon sources (HEDBACKER AND CARLSON 2008). Like AMPK,
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Snf1 is activated in response to glucose/energy limitation, which is detected by mechanisms that
include ADP binding to the γ subunit of the Snf1 complex (Snf4), which similarly protects Snf1
from dephosphorylation of the activation-loop threonine (Thr210) (MAYER et al. 2011). Snf1
serves as a good model for studying the general aspects of Snf1/AMPK regulation in eukaryotes,
and S. cerevisiae is particularly suitable for studies of the relationship between this kinase and
mitochondria because of the well-known ability of this organism to survive with its respiratory
function completely disrupted.
Using two-hybrid screening for Snf1-interacting proteins, we previously recovered the
yeast mitochondrial porin Por1 (MIHARA AND SATO 1985; FORTE et al. 1987; VYAS et al. 2001).
Mitochondrial porins, also widely known as voltage-dependent anion channel (VDAC) proteins,
are conserved in eukaryotes from yeast to humans. These proteins play key roles in mediating
mitochondrial outer membrane permeability to small metabolites, notably adenine nucleotides,
and are involved in mitochondrial respiration; VDACs also play important roles in apoptosis and
represent attractive targets for anti-cancer therapy (COLOMBINI 2004; LEMASTERS AND
HOLMUHAMEDOV 2006; SIMAMURA et al. 2008).
Here, we present evidence that the yeast mitochondrial porin Por1/yVDAC1 and its
homolog Por2/yVDAC2 (hereafter referred to as Por1 and Por2, respectively) share a role in the
positive control of Snf1, revealing a new and unexpected layer of regulation. Physical proximity
to the VDAC proteins and mitochondrial surface could facilitate Snf1’s ability to sense energy
limitation.
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Materials and methods
Yeast strains and media. The S. cerevisiae strains used in this study are listed in Table 1. Yeast
two-hybrid assays were performed in strain CTY10-5d (MATa gal4 gal80 URA3::lexAop-lacZ
his3 leu2 ade2 trp1-901) (R. Sternglanz, SUNY, Stonybrook, NY). Except for CTY10-5d and
its por1∆ derivative (see below), all strains were in the W303 background. The snf1∆::KanMX6
allele has been described (ORLOVA et al. 2006). To generate the por1∆::KanMX6 and
por2∆::KanMX6 alleles, the marker sequences were amplified by PCR with primers flanking the
corresponding open reading frames. The mutant alleles were introduced into W303-1A (MATa
ade2-1 can1–100 his3–11,15 leu2–3,112 trp1–1 ura3–1) by transformation; all yeast
transformations were performed using standard methods (ROSE et al. 1990). In addition,
por1∆::KanMX6 was introduced into CTY10-5d, and por2∆::KanMX6 was introduced into
W303-1B (MATα ade2-1 can1–100 his3–11,15 leu2–3,112 trp1–1 ura3–1). The genotypes of all
knock-out strains were confirmed by PCR analysis of genomic DNA. Double mutants lacking
Por1 and Por2 were constructed by tetrad analysis of diploid cells obtained by crossing por1∆
and por2∆ single mutants of the opposite mating types. The rho0 cells were generated in W3031A by ethidium bromide treatment (GOLDRING et al. 1970). The rho0 status of the glycerol-nonutilizing cells thus obtained was verified by the loss of the mitochondrial COX1 and COX3 genes
by PCR; the presence of the nuclear COX4 gene was used as a positive control.
Rich medium was yeast extract/peptone (YEP) supplemented with extra tryptophan (40
mg/L) and adenine (20 mg/L); synthetic complete (SC) medium lacking appropriate supplements
was used to select for plasmids (ROSE et al. 1990). Unless indicated otherwise, the media
contained 2% glucose, and cells were grown at 30oC.
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Yeast two-hybrid interaction assays. Plasmids pIT469 (KUCHIN et al. 2000) and pRJ79 (JIANG
AND CARLSON

1996) express LexA-Snf1 and VP16-Snf1 from vectors pEG202 (GOLEMIS et al.

1997) and pVP16 (VOJTEK et al. 1993), respectively. To construct pLexA-Por1 and pGADPor1, a PCR fragment encompassing the POR1 open reading frame was inserted at the BamHI
site of pEG202 and pACTII (LEGRAIN et al. 1994), respectively. The pLexA-Por1 and pGADPor1 plasmids were confirmed for ability to complement the por1∆ mutant derivative of CTY105D for the growth defect on glycerol at 37oC (BLACHLY-DYSON et al. 1997). Strain CTY10-5d
was co-transformed with pairs of plasmids expressing the protein pairs being tested.
Transformants were grown to mid-log phase with plasmid selection in SC lacking histidine and
leucine and containing 2% glucose, and then shifted for 3h to an otherwise identical medium
containing 0.05% glucose. β-Galactosidase activity was assayed in permeabilized cells and
expressed in Miller units, as described previously (VYAS et al. 2001).

Coimmunoprecipitation assays. Plasmids pHA-Por1 and pHA-Por2 express N-terminal triple
hemagglutinin (HA) epitope-tagged Por1 (HA-Por1) and HA-Por2, respectively, and were
constructed by inserting the POR1 and POR2 coding sequences into the BamHI site of vector
pWS93 (SONG AND CARLSON 1998). Cells of W303-1A carrying the snf1∆ mutation were
transformed with plasmid pSK117 expressing Snf1 (TREITEL et al. 1998) or with vector pSK134
(TREITEL et al. 1998; VINCENT et al. 2001a), and co-transformed with plasmids pHA-Por1, pHAPor2, or with vector pWS93. Cells were grown to mid-log phase with plasmid selection in SC
lacking leucine and uracil and containing 2% glucose; where indicated, cells were grown as
above and then shifted for 1h to an otherwise identical medium containing 0.05% glucose.
Protein extracts were prepared, and immunoprecipitations (from 200 mg of protein per reaction)
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were performed with anti-HA 12CA5 essentially as described previously (TREITEL et al. 1998) in
a buffer containing 0.1% Triton X-100 and 50 mM NaCl (VYAS et al. 2001). The
immunoprecipitates were examined for the presence of Snf1 by immonoblot analysis using antipolyhistidine antibody H1029 (Sigma-Aldrich), which strongly recognizes Snf1 due to the
presence of a natural stretch of 13 consecutive histidines near its N terminus (amino acids 18-30)
(ORLOVA et al. 2008)). The presence of HA-Por1 and HA-Por2 was analyzed using anti-HA.
Signals were detected by enhanced chemiluminescence using ECL Plus (Amersham Biosciences)
or HyGlo (Denville Scientiﬁc). The presence of Snf1, HA-Por1, and HA-Por2 in the extracts was
analyzed by immunoblotting similarly (10 mg protein per lane).

Analysis of SUC2-LEU2-lacZ reporter expression. To target its genomic integration, reporter
plasmid pLS11 (SAROKIN AND CARLSON 1985) was linearized at the NcoI site within the URA3
gene prior to transformation. pLS11 was first introduced into a double heterozygous diploid
(AMS2) obtained by crossing por1∆ and por2∆ single mutants. Wild-type and mutant haploids
+

carrying pLS11 (Ura ) were then recovered by tetrad analysis. The rho0 derivatives were
generated from pLS11-carrying wild-type cells as described above. Cells were grown to mid-log
phase in YEP with 2% glucose and then shifted to YEP with 0.05% glucose for 3h.
β-Galactosidase activity was assayed in permeabilized cells and expressed in Miller units.
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Results

Snf1 and Por1 interact in the two-hybrid system
Por1 was recovered previously by S.K. from a two-hybrid screen for Snf1-interacting
proteins (VYAS et al. 2001). To further demonstrate this interaction, fusions to the LexA DNAbinding protein were tested in combination with fusions to the viral VP16 or Gal4 transcription
activation domain (GAD) for ability to activate a reporter with LexA binding sites (lexAop-lacZ)
in strain CTY10-5d. LexA-Por1 interacted with VP16-Snf1 (Fig. 7A). In the reciprocal setting,
LexA-Snf1 interacted with GAD-Por1 (Fig. 7B). In both cases, the interaction signals exhibited
an apparent increase in response to glucose limitation. As discussed further below, we do not
necessarily take this to suggest that the affinity of the Snf1-Por1 interaction is stimulated by
glucose limitation.
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Fig. 7. Snf1 and Por1 interact in the two-hybrid system. Strain CTY10-5d with an integrated lexAop-lacZ reporter
was co-transformed with pairs of plasmids expressing the indicated proteins. β-Galactosidase activity was assayed
in mid-log cultures grown in selective medium with high (2%) glucose (open bars) and shifted for 3h to an otherwise
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identical medium with low (0.05%) glucose (closed bars). Values are averages for at least three transformants and
are expressed in Miller units (U). Error bars indicate standard errors. Asterisks indicate statistically significant
difference from the corresponding controls (p < 0.03 both in high and low glucose). (A) LexA-Por1 interacts with
VP16-Snf1. (B) LexA-Snf1 interacts with GAD-Por1.

In terms of β-galactosidase activity, the observed interaction was weak by comparison to
other known interactions of Snf1 (e.g. within the classical Snf1 complex (JIANG AND CARLSON
1996)), which was not surprising; in fact, it was more surprising that this interaction could be
detected at all. In order for a two-hybrid interaction to be detected, both interacting partners
must be present in the nucleus. While this is not a problem for Snf1, which is a
cytoplasmic/nuclear protein (VINCENT et al. 2001b), Por1 is a major mitochondrial outer
membrane protein (BLACHLY-DYSON et al. 1997). However, porin/VDAC proteins are
apparently not absolutely restricted from the nucleus, allowing the yeast two-hybrid system to
work and provide valuable preliminary information. For example, some interactions of
eukaryotic VDAC proteins that were initially detected in the yeast two-hybrid system were
subsequently shown to exist and to be physiologically relevant (FENG et al. 2007; CHEN et al.
2009). We therefore decided to explore the Snf1-Por1 interaction further.

Snf1 coimmunoprecipitates with Por1
We next conducted coimmunoprecipitation experiments. A snf1∆ strain was cotransformed with plasmids expressing Snf1 and HA-Por1. Cells were grown to mid-log phase in
abundant glucose, protein extracts were prepared and subjected to immunoprecipitation with
anti-HA. The immunoprecipitates were then tested for the presence of Snf1 by immunoblot
analysis. Snf1 was detected in the immunoprecipitates from cells expressing both HA-Por1 and
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Snf1, but not from cells expressing HA-Por1 but no Snf1, or expressing Snf1 but no HA-Por1
(Fig. 8A). Thus, these results provided further evidence that Snf1 interacts with Por1.
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Fig. 8. Snf1 coimmunoprecipitates with Por1 and Por2. (A, B) Snf1 coimmunoprecipitates with HA-Por1. (A) Cells
carrying the snf1∆ mutation (isogenic to W303-1A) were transformed with a plasmid expressing Snf1 (Snf1: +) or
the appropriate vector (Snf1: -), as well as with a plasmid expressing HA-Por1 (HA-Por1, +) or the appropriate
vector (HA-Por1, -). Cells were grown to mid-log phase with plasmid selection in media containing 2% glucose,
protein extracts were prepared, and HA-Por1 was immunoprecipitated with anti-HA. The presence of Snf1 and HAPor1 in the extracts (Extract) and immunoprecipitates (IP: a-HA) was examined by immunoblotting. (B) Cells coexpressing Snf1 and HA-Por1 were grown in 2% glucose as for panel A (H, high glucose), and then shifted for 1h to
an otherwise identical medium with 0.05% glucose (L, low glucose). Coimmunoprecipitation experiments were
performed as for panel A. (C, D) Snf1 coimmunoprecipitates with HA-Por2. Experiments in panels C and D were
performed as for panels A and B, respectively, except that HA-Por2 was expressed instead of HA-Por1.

We also compared the ability of Snf1 to coimmunoprecipitate with Por1 in high and low
glucose conditions. In contrast to the two-hybrid experiments, there was no apparent increase in
interaction upon shift from high to low glucose (Fig. 8B). It should be noted that the apparent
strength of a two-hybrid interaction reflects not only interaction affinity, but also the nuclear
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content of the interaction partners. The latter factor could at least partly account for the
increased two-hybrid signal in low glucose, since there is more Snf1 in the nucleus under carbon
stress conditions (VINCENT et al. 2001b). In addition, the lexAop-lacZ two-hybrid reporter could
be more responsive to activation in low glucose, since this reporter is constructed on the basis of
the GAL1 promoter, which is glucose-regulated (WEST et al. 1984; JOHNSTON 1987).

Lack of Por1 and its homolog Por2 affects Snf1 activation
S. cerevisiae has two VDAC isoforms, Por1 and Por2. Por2 is 49% identical and 70%
similar to Por1 and similarly localizes to the mitochondrial outer membrane (BLACHLY-DYSON et
al. 1997; ZAHEDI et al. 2006). Unlike Por1, however, Por2 does not appear to possess channel
function (BLACHLY-DYSON et al. 1997; LEE et al. 1998). Unlike the por1∆ mutation, the por2∆
mutation alone does not affect growth on non-fermentable carbon sources, but nonetheless
enhances por1∆ for this defect (BLACHLY-DYSON et al. 1997). This and other evidence strongly
suggested the existence of a mechanism where Por1 and Por2 share a role in non-fermentable
carbon source utilization that is not directly related to channel function (BLACHLY-DYSON et al. ;
LEE et al. 1998). Since Snf1 is required for growth on non-fermentable carbon sources
(HEDBACKER AND CARLSON 2008), and since Snf1 also coimmunoprecipitates with Por2 (Fig.
8C, D), we considered the possibility that Por1 and Por2 share a role in the positive control of
Snf1.
Catalytic activation of Snf1 requires phosphorylation of its conserved activation-loop
threonine (Thr210, which corresponds to Thr172 of AMPK) that is performed by the upstream
kinases Sak1, Tos3, and Elm1 (HONG et al. 2003; NATH et al. 2003; SUTHERLAND et al. 2003).
In the presence of abundant glucose, Snf1 is turned off by Thr210 dephosphorylation, which
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involves type 1 protein phosphatase Glc7 together with its regulatory protein Reg1 (TU AND
CARLSON 1994; TU AND CARLSON 1995; MCCARTNEY AND SCHMIDT 2001). When wild-type
cells are shifted from high to low glucose, the level of activated phospho-Thr210-Snf1 increases
dramatically (MCCARTNEY AND SCHMIDT 2001). In comparison to the wild type, double mutant
cells lacking Por1 and Por2 exhibited a lower level of phospho-Thr210-Snf1, as hypothesized
(Fig. 9A), with a reduction of approximately 5-fold upon normalization to total Snf1 levels. No
such Snf1 activation defects were observed in cells lacking Por1 alone, Por2 alone, or in
respiratory-deficient rho0 cells lacking the mitochondrial genome (Fig. 9B), with the normalized
phospho-Thr210-Snf1 levels in these mutants and the wild type differing from each other by no
more than 30%.
Thus, these results indicated that the combined lack of Por1 and Por2 confers a defect in
Snf1 activation loop phosphorylation in low glucose, and that this defect is not directly related to
compromised respiratory competence.
We also examined the effects of the mutations on the regulation of an integrated SUC2LEU2-lacZ reporter; expression of this reporter is activated by glucose limitation in a Snf1dependent manner (SAROKIN AND CARLSON 1985). Under glucose-limiting conditions, the
por1∆ por2∆ double mutation caused a 13-fold reporter activation defect relative to the wild type
(Fig. 9C). Interestingly, the por1∆ and rho0 mutations also affected activation, albeit to a lesser
extent (2.5-fold and 4.1-fold, respectively), raising the possibility that these mutations affect yet
another aspect of Snf1 pathway activity that is distinct from Thr210 phosphorylation, as
discussed in Chapters 4 and 5.
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Fig. 9. Lack of Por1 and Por2 affects Snf1 activation. (A, B) Cells of the indicated genotypes (isogenic to W3031A) were grown to mid-log phase in YEP containing 2% glucose (H, high glucose) and shifted for 60 min (A) or 90
min (B) to YEP containing 0.05% glucose (L, low glucose). The activation-loop Thr210 phosphorylation status of
Snf1 was analyzed by immunoblotting as described previously (ORLOVA et al. 2008): phospho-Thr210-Snf1
(PT210) was detected with anti-phospho-Thr172-AMPK (Cell Signaling Technology), and the total Snf1 protein
(Snf1) was detected by re-probing with anti-polyhistidine antibody H1029 (Sigma-Aldrich), which recognizes the
natural stretch of 13 histidines present in Snf1. (C) Cells of the indicated genotypes with an integrated SUC2-LEU2lacZ reporter were grown to mid-log phase in YEP with 2% glucose (H, high glucose) and then shifted to YEP with
0.05% glucose for 3h (L, low glucose). β-Galactosidase activity was assayed in permeabilized cells and expressed in
Miller units (U). Values are averages for four to six assays. Error bars indicate standard errors. For low glucose
conditions, the value for the por1∆ por2∆ double mutant was significantly different from any other value (p <
0.001), and the values for por1∆ and rho0 were significantly different from any other value and from each other (p <

Fig. 3

0.003). Under high glucose conditions, the values were 4.7 units (for the wild type) or lower.
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Discussion
In this study, we present evidence that the yeast mitochondrial VDAC proteins Por1 and
Por2 contribute to the positive control of Snf1 activation-loop phosphorylation, and this role is
not directly mediated by the respiratory proficiency of the cell.
The VDAC proteins represent a major component of the interface between the
mitochondria and cytoplasm of the eukaryotic cell (COLOMBINI 2004). Proteomic studies in
yeast indicate that Por1 and Por2 physically interact with numerous proteins, including
components of major nutrient-sensing pathways such as TOR, PKA, casein kinase II, and others
(HO et al. 2002); the ability of Snf1 to interact with Por1 and Por2 is also consistent with the
previous finding that Snf1 associates with the mitochondria (SICKMANN et al. 2003). If the
mitochondrial surface serves as a major substratum for interactions between global regulatory
pathways, the Snf1 activation defect observed in the por1∆ por2∆ mutant could represent an
indirect consequence of major pathway miscommunication caused by mitochondrial surface
perturbation.
However, Por1 and Por2 could also at least partly contribute to Snf1 regulation by a more
direct mechanism. Similar to mammalian AMPK, Snf1 activation correlates with increased
AMP-to-ATP ratios in vivo; unlike AMPK, however, the yeast Snf1 complex does not respond to
regulation by AMP in vitro (WILSON et al. 1996; ADAMS et al. 2004). The identity of the
relevant in-vivo AMP and/or ATP sensor, if it exists, remains unknown. Following the recent
findings that mammalian AMPK is positively regulated by ADP (OAKHILL et al. 2011; XIAO et
al. 2011), it was shown that ADP binding to Snf4 protects yeast Snf1 from Thr210
dephosphorylation in vitro (MAYER et al. 2011). Based on analysis of ADP and ATP binding
affinities, it was suggested that the yeast Snf1 complex responds to absolute ADP levels rather
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than to ADP-to-ATP ratios (MAYER et al. 2011). At the same time, according to an earlier report
(WILSON et al. 1996), the absolute ADP levels in yeast cells grown in high and low glucose do
not appear to differ as much as the AMP-to-ATP or ADP-to-ATP ratios. These considerations
suggest a possible functional niche for Por1 and Por2. We envision that an ability to interact with
the VDAC proteins and proximity to the mitochondrial surface could put Snf1 complex in a
better position to sense glucose/energy limitation. For example, as glucose levels decrease, the
ADP levels could rise more sharply at the mitochondrial surface, making it a good location to
monitor. In other words, the VDAC proteins could assist the γ subunit, Snf4, in sensing the local
change in ADP levels. Alternatively, the VDAC proteins could be more directly involved in the
regulation of Snf1 in a Snf4-independent manner, i.e. they may themselves serve as “sensors” of
an energy stress signal/ligand. For example, the VDACs could serve as sensors of nucleotides,
e.g. AMP, ADP, ATP, NADH, NAD+, etc., or other metabolites, e.g. glucose-6-phosphate.
Further experiments will be necessary to address these and other possibilities.

Table 1. S. cerevisiae strains

1

Strain

Genotype

Source

MMY35

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This lab

YSK1279

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 por1Δ::KanMX6

This study

YSK1280

MATα his3–11,15 leu2–3,112 trp1–1 ura3–1 por1Δ::KanMX6

This study

YSK1283

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 por2Δ::KanMX6

This study

AMS125

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 snf1Δ::KanMX6

This study

AMS2

YSK1280 X YSK1283

This study
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AMS10

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 por1Δ::KanMX6

This study

por2Δ::KanMX6
AMS-R0

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 rho0

This study

CTY10-5d

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

R. Sternglanz

YSK1271

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

This study

por1Δ::KanMX6

References
Adams, J., Z. P. Chen, B. J. Van Denderen, C. J. Morton, M. W. Parker et al., 2004 Intrasteric
control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci 13:
155-165.
Blachly-Dyson, E., J. Song, W. J. Wolfgang, M. Colombini and M. Forte, 1997 Multicopy
suppressors of phenotypes resulting from the absence of yeast VDAC encode a VDAClike protein. Mol Cell Biol 17: 5727-5738.
Brunmair, B., K. Staniek, F. Gras, N. Scharf, A. Althaym et al., 2004 Thiazolidinediones, like
metformin, inhibit respiratory complex I: a common mechanism contributing to their
antidiabetic actions? Diabetes 53: 1052-1059.
Chen, Y., W. J. Craigen and D. J. Riley, 2009 Nek1 regulates cell death and mitochondrial
membrane permeability through phosphorylation of VDAC1. Cell Cycle 8: 257-267.
Colombini, M., 2004 VDAC: the channel at the interface between mitochondria and the cytosol.
Mol Cell Biochem 256-257: 107-115.
Dowling, R. J., S. Niraula, V. Stambolic and P. J. Goodwin, 2012 Metformin in cancer:
translational challenges. J Mol Endocrinol 48: R31-43.
El-Mir, M. Y., V. Nogueira, E. Fontaine, N. Averet, M. Rigoulet et al., 2000 Dimethylbiguanide
inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.
J Biol Chem 275: 223-228.
Feng, P., C. Liang, Y. C. Shin, E. Xiaofei, W. Zhang et al., 2007 A novel inhibitory mechanism
of mitochondrion-dependent apoptosis by a herpesviral protein. PLoS Pathog 3: e174.
Fogarty, S., and D. G. Hardie, 2009 Development of protein kinase activators: AMPK as a target
in metabolic disorders and cancer. Biochim Biophys Acta 1804: 581-591.
Forte, M., H. R. Guy and C. A. Mannella, 1987 Molecular genetics of the VDAC ion channel:
structural model and sequence analysis. J Bioenerg Biomembr 19: 341-350.
Goldring, E. S., L. I. Grossman, D. Krupnick, D. R. Cryer and J. Marmur, 1970 The petite
mutation in yeast. Loss of mitochondrial deoxyribonucleic acid during induction of
petites with ethidium bromide. J Mol Biol 52: 323-335.
Golemis, E. A., I. Serebriiskii, J. Gjuris and R. Brent, 1997 Current Protocols in Molecular
Biology. Wiley, New York.

36

Hardie, D. G., 2007a AMP-activated protein kinase as a drug target. Annu Rev Pharmacol
Toxicol 47: 185-210.
Hardie, D. G., 2007b AMP-activated/SNF1 protein kinases: conserved guardians of cellular
energy. Nat Rev Mol Cell Biol 8: 774-785.
Hardie, D. G., 2007c AMPK and SNF1: Snuffing Out Stress. Cell Metab 6: 339-340.
Hardie, D. G., and D. Carling, 1997 The AMP-activated protein kinase--fuel gauge of the
mammalian cell? Eur J Biochem 246: 259-273.
Hedbacker, K., and M. Carlson, 2008 SNF1/AMPK pathways in yeast. Front Biosci 13: 24082420.
Ho, Y., A. Gruhler, A. Heilbut, G. D. Bader, L. Moore et al., 2002 Systematic identification of
protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415: 180183.
Hong, S. P., F. C. Leiper, A. Woods, D. Carling and M. Carlson, 2003 Activation of yeast Snf1
and mammalian AMP-activated protein kinase by upstream kinases. Proc Natl Acad Sci
U S A 100: 8839-8843.
Jiang, R., and M. Carlson, 1996 Glucose regulates protein interactions within the yeast SNF1
protein kinase complex. Genes Dev. 10: 3105-3115.
Johnston, M., 1987 A model fungal gene regulatory mechanism: the GAL genes of
Saccharomyces cerevisiae. Microbiol Rev 51: 458-476.
Kahn, B. B., T. Alquier, D. Carling and D. G. Hardie, 2005 AMP-activated protein kinase:
ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab
1: 15-25.
Kuchin, S., I. Treich and M. Carlson, 2000 A regulatory shortcut between the Snf1 protein
kinase and RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 97: 7916-7920.
Lee, A. C., X. Xu, E. Blachly-Dyson, M. Forte and M. Colombini, 1998 The role of yeast VDAC
genes on the permeability of the mitochondrial outer membrane. J Membr Biol 161: 173181.
Legrain, P., M. C. Dokhelar and C. Transy, 1994 Detection of protein-protein interactions using
different vectors in the two-hybrid system. Nucleic Acids Res 22: 3241-3242.
Lemasters, J. J., and E. Holmuhamedov, 2006 Voltage-dependent anion channel (VDAC) as
mitochondrial governator--thinking outside the box. Biochim Biophys Acta 1762: 181190.
Mayer, F. V., R. Heath, E. Underwood, M. J. Sanders, D. Carmena et al., 2011 ADP regulates
SNF1, the Saccharomyces cerevisiae homolog of AMP-activated protein kinase. Cell
Metab 14: 707-714.
McCartney, R. R., and M. C. Schmidt, 2001 Regulation of Snf1 kinase. Activation requires
phosphorylation of threonine 210 by an upstream kinase as well as a distinct step
mediated by the Snf4 subunit. J Biol Chem 276: 36460-36466.
Mihara, K., and R. Sato, 1985 Molecular cloning and sequencing of cDNA for yeast porin, an
outer mitochondrial membrane protein: a search for targeting signal in the primary
structure. EMBO J 4: 769-774.
Nath, N., R. R. McCartney and M. C. Schmidt, 2003 Yeast Pak1 kinase associates with and
activates Snf1. Mol Cell Biol 23: 3909-3917.
Oakhill, J. S., R. Steel, Z. P. Chen, J. W. Scott, N. Ling et al., 2011 AMPK is a direct adenylate
charge-regulated protein kinase. Science 332: 1433-1435.

37

Orlova, M., L. Barrett and S. Kuchin, 2008 Detection of endogenous Snf1 and its activation
state: application to Saccharomyces and Candida species. Yeast 25: 745-754.
Orlova, M., E. Kanter, D. Krakovich and S. Kuchin, 2006 Nitrogen availability and TOR
regulate the Snf1 protein kinase in Saccharomyces cerevisiae. Eukaryot Cell 5: 18311837.
Rose, M. D., F. Winston and P. Hieter, 1990 Methods in yeast genetics: A laboratory course
manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
Sarokin, L., and M. Carlson, 1985 Upstream region of the SUC2 gene confers regulated
expression to a heterologous gene in Saccharomyces cerevisiae. Mol Cell Biol 5: 25212526.
Sickmann, A., J. Reinders, Y. Wagner, C. Joppich, R. Zahedi et al., 2003 The proteome of
Saccharomyces cerevisiae mitochondria. Proc Natl Acad Sci U S A 100: 13207-13212.
Simamura, E., H. Shimada, T. Hatta and K. Hirai, 2008 Mitochondrial voltage-dependent anion
channels (VDACs) as novel pharmacological targets for anti-cancer agents. J Bioenerg
Biomembr 40: 213-217.
Song, W., and M. Carlson, 1998 Srb/Mediator proteins interact functionally and physically with
transcriptional repressor Sfl1. EMBO J 17: 5757-5765.
Strogolova, V., M. Orlova, A. Shevade and S. Kuchin, 2012 Mitochondrial porin Por1 and its
homolog Por2 contribute to the positive control of Snf1 protein kinase in Saccharomyces
cerevisiae. Eukaryot Cell 11: 1568-1572.
Sutherland, C. M., S. A. Hawley, R. R. McCartney, A. Leech, M. J. Stark et al., 2003 Elm1p is
one of three upstream kinases for the Saccharomyces cerevisiae SNF1 complex. Curr
Biol 13: 1299-1305.
Treitel, M. A., S. Kuchin and M. Carlson, 1998 Snf1 protein kinase regulates phosphorylation of
the Mig1 repressor in Saccharomyces cerevisiae. Mol Cell Biol 18: 6273-6280.
Tu, J., and M. Carlson, 1994 The GLC7 type 1 protein phosphatase is required for glucose
repression in Saccharomyces cerevisiae. Mol Cell Biol 14: 6789-6796.
Tu, J., and M. Carlson, 1995 REG1 binds to protein phosphatase type 1 and regulates glucose
repression in Saccharomyces cerevisiae. EMBO J 14: 5939-5946.
Vakana, E., and L. C. Platanias, 2011 AMPK in BCR-ABL expressing leukemias. Regulatory
effects and therapeutic implications. Oncotarget 2: 1322-1328.
Vincent, O., S. Kuchin, S. P. Hong, R. Townley, V. K. Vyas et al., 2001a Interaction of the
Srb10 kinase with Sip4, a transcriptional activator of gluconeogenic genes in
Saccharomyces cerevisiae. Mol Cell Biol 21: 5790-5796.
Vincent, O., R. Townley, S. Kuchin and M. Carlson, 2001b Subcellular localization of the Snf1
kinase is regulated by specific beta subunits and a novel glucose signaling mechanism.
Genes Dev 15: 1104-1114.
Vojtek, A. B., S. M. Hollenberg and J. A. Cooper, 1993 Mammalian Ras interacts directly with
the serine/threonine kinase Raf. Cell 74: 205-214.
Vyas, V. K., S. Kuchin and M. Carlson, 2001 Interaction of the repressors Nrg1 and Nrg2 with
the Snf1 protein kinase in Saccharomyces cerevisiae. Genetics 158: 563-572.
West, R. W., Jr., R. R. Yocum and M. Ptashne, 1984 Saccharomyces cerevisiae GAL1-GAL10
divergent promoter region: location and function of the upstream activating sequence
UASG. Mol Cell Biol 4: 2467-2478.

38

Wilson, W. A., S. A. Hawley and D. G. Hardie, 1996 Glucose repression/derepression in
budding yeast: SNF1 protein kinase is activated by phosphorylation under derepressing
conditions, and this correlates with a high AMP:ATP ratio. Curr Biol 6: 1426-1434.
Xiao, B., M. J. Sanders, E. Underwood, R. Heath, F. V. Mayer et al., 2011 Structure of
mammalian AMPK and its regulation by ADP. Nature 472: 230-233.
Zahedi, R. P., A. Sickmann, A. M. Boehm, C. Winkler, N. Zufall et al., 2006 Proteomic analysis
of the yeast mitochondrial outer membrane reveals accumulation of a subclass of
preproteins. Mol Biol Cell 17: 1436-1450.

39

Chapter 3
Mitochondrial porins as sensors of a signal that regulates the Snf1/AMPK pathway

Abstract
The heterotrimeric Snf1 protein kinase in the yeast Saccharomyces cerevisiae plays an important
role in sensing and responding to nutrient/energy stress such as during glucose limitation. The Nterminal region of the catalytic a subunit, Snf1, contains the kinase domain (Snf1-KD). Snf1-KD
contains the activation-loop Thr210 residue that is phosphorylated during glucose limitation.
Previous in-vitro experiments showed that ADP binding to the so-called “sensory” γ subunit,
Snf4, protects Snf1 Thr210 from dephosphorylation by phosphatases. However, the
physiological relevance of this mechanism of sensing energy/glucose stress remains
controversial. The voltage dependent anion channel (VDAC) proteins allow the flux of small
metabolites, including ATP, ADP, and AMP, between the cytoplasm and the outer membrane of
mitochondria. As such, VDACs are in an excellent position to sense the energy status of the cell.
In the previous chapter we have shown that yeast cells lacking mitochondrial VDAC proteins,
Por1 and Por2, exhibit a defect in the catalytic activation of Snf1 under glucose limiting
conditions. Here, we present evidence that Por1 interacts with Snf1-KD in the two-hybrid
system, and that Por1 and Por2 are required for normal Thr210 phosphorylation of Snf1-KD.
Since Snf1-KD is regulated independently of the “sensory” Snf4 subunit, our results suggest that
VDACs can independently sense a signal that regulates Snf1. Moreover, genetic evidence
suggests that Por1 and Por2 function downstream of hexokinase 2 (Hxk2), a negative regulator
of Snf1, raising the possibility that one of the signals sensed by VDACs is a glucose metabolite,
presumably glucose-6-phosphate.
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Introduction
The Snf1/AMPK family of protein kinases senses the energy status and regulates
metabolic processes in eukaryotes. Mammalian AMPK (AMP-activated protein kinase) is often
called the cell’s “fuel gauge”, as AMPK monitors the AMP:ATP ratio, and during energy stress,
it turns on ATP-generating processes and switches off ATP-consuming processes (HARDIE AND
CARLING 1997). In conditions such as hypoglycemia and hypoxia, when the AMP-to-ATP ratio
is high, AMP binds to the γ subunit of AMPK leading to a conformational change. This helps the
upstream kinases to activate AMPK by phosphorylation of the conserved activation-loop Thr172
residue present in the catalytic α subunit. Binding of AMP also protects AMPK from
deactivation by phosphatases that remove the phosphate group. Upon activation, AMPK
promotes uptake of glucose and fatty acids, activates catabolic processes such as glycolysis and
fatty acid breakdown, and stimulates mitochondrial respiration to increase ATP production.
Moreover, active AMPK conserves energy by inhibiting anabolic processes and slowing down
cell growth and proliferation. Due to its critical roles, impairment in the AMPK pathway can
lead to obesity, type 2 diabetes, cardiovascular disorders, cancer, and other diseases (FOGARTY
AND HARDIE

2009; HARDIE et al. 2012).

The AMPK homolog of budding yeast, Snf1, serves as an important model for studying
general aspects of AMPK regulation and function. Whenever the preferred carbon source,
glucose is limiting, Snf1 helps cells to adapt and utilize alternative carbon sources, as well as
switch on mitochondrial respiration (HEDBACKER AND CARLSON 2008). Like AMPK, Snf1
protein kinase is a heterotrimeric complex consisting of the catalytic α subunit Snf1, three
alternative scaffolding/targeting β subunits (Sip1, Sip2, and Gal83), and the “sensory” γ subunit
Snf4. Snf1 is activated by phosphorylation of its activation-loop Thr210 residue under glucose

41

limiting conditions. In the native complex, Snf4 binds to the C-terminal regulatory domain
(Snf1-RD) of Snf1, which allows the N-terminal kinase domain (Snf1-KD) to become accessible
for phosphorylation by upstream kinases. In-vitro experiments have shown that ADP can bind to
Snf4 and protect Snf1 from phosphatases. However, the physiological relevance of this finding
remains unclear, especially considering the fact that Snf1 remains glucose-regulated in the snf4∆
mutant (MCCARTNEY AND SCHMIDT 2001). Furthermore, Thr210 phosphorylation of the isolated
Snf1-KD remains glucose-regulated, meaning that at its core, Snf1 regulation by glucose does
not require the β and γ subunits or the C-terminal non-catalytic domain (RUIZ et al. 2012).
Therefore, the nature of the Snf1-regulating signal and the mechanism of its sensing are not
completely understood.
Voltage-dependent anion channel (VDAC) proteins – also known as mitochondrial porins
- are highly conserved among eukaryotes and allow the passage of small metabolites, including
adenine nucleotides, between the cytoplasm and the mitochondria (COLOMBINI 2004). Porins
play an important role in respiration and are an important drug target because of their roles in
apoptosis and cancer (SIMAMURA et al. 2008; SHOSHAN-BARMATZ AND BEN-HAIL 2011).
In the previous chapter, we have shown that the yeast VDAC proteins, Por1 and Por2,
interact with Snf1 and positively regulate its catalytic activation. How the porins affect Snf1
activation remains unclear. In this study, we present evidence that Por1 and Por2 regulate the
activation of the heterotrimer-independent Snf1-KD. We also show that Por1 and Por2 function
downstream of hexokinase 2 (Hxk2), a glycolytic enzyme that is known to play a role in Snf1
inhibition in the presence of glucose. Indeed, the triple knock-out mutant lacking Hxk2, Por1,
and Por2 shows reduced Snf1 Thr210 phosphorylation just as the por1∆ por2∆ double mutant.
Our results suggest that Por1 and Por2 play a role as heterotrimer-independent sensors in the
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regulation of Thr210 phosphorylation, and raise the possibility that one of the metabolites sensed
by Por1 and Por2 is glucose-6-phosphate.

Materials and Methods
Yeast strains and media. The S. cerevisiae strains used in this study are listed in Table 2.
Except for strain CTY10-5d (R. Sternglanz, SUNY, Stony Brook, NY) used for yeast two-hybrid
assays, all strains were in the W303 genetic background. To generate the por1∆::KanMX6,
por2∆::KanMX6, and hxk2Δ::HisMX6 alleles, the marker sequences were amplified by PCR with
primers flanking the corresponding open reading frames. Construction of the snf1∆ has been
described previously (ORLOVA et al. 2006). Double mutants lacking Por1 and Por2 were
constructed by tetrad analysis of diploid cells obtained by crossing por1∆ and por2∆ single
mutants of the opposite mating types. Haploid cells expressing Snf1-KD (strains CGY5 and
CGY6) were constructed as follows. First, plasmid pCG2 containing the SNF1-KD sequence and
the URA3 selectable marker (see below) was linearized by digesting with BglII (within the SNF1
sequence) and integrated into the SNF1 locus of the wild-type diploid MMY25 using a standard
transformation protocol (ROSE et al. 1990). Next, haploid strains expressing Snf1-KD were
recovered by tetrad analysis. To create por1∆ and por2∆ mutants expressing Snf1-KD, strains
YSK1279 (por1∆::KanMX6) and YSK1283 (por2∆::KanMX6) were crossed to strain CGY6, and
Kan+ Ura+ segregants were obtained by tetrad analysis. The por1∆ por2∆ double mutants
expressing Snf1-KD were constructed by tetrad analysis of a diploid strain obtained by crossing
por1∆ and por2∆ single mutants of the opposite mating types, each expressing Snf1-KD. The
hxk2∆ por1∆ and hxk2∆ por2∆ double mutants were constructed by crossing AMS132
(hxk2∆::HisMX6) to AMS32 (por1∆::KanMX6) and AMS39 (por2∆::KanMX6), respectively,
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followed by tetrad analysis. The hxk2∆ por1∆ por2∆ triple mutants were constructed by tetrad
analysis of diploid cells obtained by crossing AMS161 (hxk2∆::HisMX6 por1∆::KanMX6) and
AMS164 (hxk2∆::HisMX6 por2∆::KanMX6) double mutants of the opposite mating types. The
genotypes of all strains were confirmed by PCR analysis of genomic DNA. Strains AMS32,
AMS39, AMS47, AMS161, and AMS164 also contain an integrated SUC2-LEU2-lacZ reporter
(SAROKIN AND CARLSON 1985).
Rich medium was yeast extract-peptone (YEP) supplemented with extra tryptophan (40
mg/liter) and adenine (20 mg/liter); synthetic complete (SC) medium lacking appropriate
supplements was used to select for plasmids (ROSE et al. 1990). Unless indicated otherwise, the
media contained 2% glucose, and yeast cells were grown at 30oC.

Yeast two-hybrid assays. Plasmid pLexA-Snf1-KD expresses a LexA-Snf1-KD fusion and
contains the fragment encoding Snf1-KD that was described previously and can complement the
snf1∆ mutation (JIANG AND CARLSON 1996). In control experiments, LexA was expressed from
plasmid pEG202 (GOLEMIS et al. 1997). To construct pGAD-Por1, a PCR fragment
encompassing the POR1 open reading frame was inserted at the BamHI site of pACTII
(LEGRAIN et al. 1994). The pGAD-Por1 plasmid was confirmed for ability to complement the
por1∆ mutant derivative of CTY10-5D for the growth defect on glycerol at 370C (BLACHLYDYSON et al. 1997). Strain CTY10-5d was co-transformed with pairs of plasmids expressing the
protein pairs being tested. Transformants were grown to mid-log phase with plasmid selection in
SC lacking histidine and leucine and containing 2% glucose, and then shifted for 3h to an
otherwise identical medium containing 0.05% glucose. β-Galactosidase activity was assayed in
permeabilized cells and expressed in Miller units, as described previously (VYAS et al. 2001).
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Plasmid construction. Plasmid pCG2 was constructed by ligating a PCR-amplified SNF1-KD
fragment including ~ 600 bp of the 5’ regulatory region into the BamHI site of pRS306, an
integrating vector with the URA3 selectable marker (SIKORSKI AND HIETER 1989). Expression of
Snf1-KD was confirmed by immunoblotting (see below).

Immunoblotting. Cells were grown to mid-log phase in YEP containing 2% glucose and then
shifted for 1h to an otherwise identical medium containing 0.05% glucose. Protein extracts were
prepared using the boiling/alkaline lysis method and were examined for the presence of Snf1 and
Snf1-KD by using anti-polyhistidine antibody H1029 (Sigma-Aldrich), which strongly
recognizes Snf1 due to the presence of a natural stretch of 13 consecutive histidines near its N
terminus (amino acids 18-30) (ORLOVA et al. 2008). Thr-210 phosphorylation of Snf1 and Snf1KD was determined by using anti-phospho-Thr172-AMPK antibody (Cell Signaling
Technology). Signals were detected by enhanced chemiluminescence using Pierce ECL2 or
HyGlo (Denville Scientific).

Analysis of SUC2-LEU2-lacZ reporter expression. Cells carrying the integrated SUC2-LEU2lacZ reporter (SAROKIN AND CARLSON 1985) were grown to mid-log phase in YEP with 2%
glucose and then shifted to YEP with 0.05% glucose for 3h. β-Galactosidase activity was
assayed in permeabilized cells and expressed in Miller units, as described previously (VYAS et
al. 2001).
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Results
Por1 and Por2 regulate Thr210 phosphorylation of Snf1-KD
Our previous results show that the lack of Por1 and Por2 reduces Snf1 Thr210
phosphorylation in glucose-limiting conditions. Interestingly, the channel function of the porins
does not appear to be important for this regulation because Por2, which is a non-channel forming
porin, acts redundantly with Por1 in Snf1 activation (BLACHLY-DYSON et al. 1997). Moreover,
since respiratory deficient rho0 cells activate Snf1 normally, the defect in the activation of Snf1
is not directly related to the respiratory deficiency of the por1∆ por2∆ cells. Thus, the regulatory
function of Por1 and Por2 in the Snf1 pathway is separable from their channel activity and role
in respiration. We wanted to investigate further the role played by the porins in the catalytic
activation of Snf1. One important question to address was whether Por1 and Por2 simply
facilitate Snf1 regulation via the regulatory subunits – particularly the “sensory” γ subunit Snf4 of the kinase complex, or whether they have an independent role. The latter possibility stems
from the fact that Snf1 remains glucose-regulated in the snf4∆ mutant, and that the isolated Snf1KD that is not associated with the rest of the complex is regulated by glucose in vivo
(MCCARTNEY AND SCHMIDT 2001; RUIZ et al. 2012). We therefore decided to test the ability of
the porins to regulate the catalytic activation of Snf1-KD.
Wild-type and mutant cells were grown to mid-log phase in the presence of high (2%)
glucose and then shifted to low (0.05%) glucose for 60 min. The phosphorylation status of Snf1KD was determined by immunoblotting. The por1∆ por2∆ double mutant exhibited reduced
Thr210 phosphorylation of Snf1-KD compared to the wild type (Fig. 10). No such Snf1-KD
activation defects were observed in cells lacking Por1 alone and Por2 alone (data not shown).
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Fig. 10. Roles of Por1 and Por2 in the activation of the Snf1 kinase domain. Cells of the indicated genotypes
expressing the Snf1 kinase domain (Snf1-KD) were grown to mid-log phase in YEP containing 2% glucose (H, high
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glucose) and shifted for 60 min to YEP containing 0.05% glucose (L, low glucose). Thr-210 phosphorylation

dependent on the formation of a stable Snf1 heterotrimeric complex. The C-terminal domain of
the catalytic a subunit Snf1 mediates its interaction with the β and γ subunits of the
heterotrimeric complex (JIANG AND CARLSON 1996; JIANG AND CARLSON 1997). In contrast, the
N-terminal kinase domain (Snf1-KD lacking the C-terminal domain) does not bind to the β and γ
subunits; nonetheless, it is glucose-regulated and can associate with the Snf1 upstream kinase
Sak1 and retains functionality in vivo (LUDIN et al. 1998; LIU et al. 2011). Since Por1 and Por2
play a role in the activation of Snf1-KD, we first examined if Por1 can interact with this domain.
To this end, we used the yeast two-hybrid system. A Snf1-KD fusion to the LexA DNA-binding
protein was tested in combination with a Por1 fusion to the Gal4 transcription activation domain
(GAD) for ability to activate a reporter with LexA binding sites (lexAop-lacZ) in strain CTY105d. LexA-Snf1-KD interacted with GAD-Por1 (Fig. 11). The interaction was observed under
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high and low glucose conditions, and its apparent strength was comparable to that of the
interaction between Por1 and full-size Snf1 (see Fig. 7 in Chapter 2). Thus, these results
strongly suggest that Por1 can interact with Snf1-KD, and that this interaction is independent of
the β and γ subunits of the Snf1 complex.
We also attempted to examine the two-hybrid interaction between Snf1-KD and Por2, but
the results were inconclusive and are not shown. Since Por1 and Por2 function redundantly in the
regulation of Snf1-KD, we envision that Por2 similarly interacts with Snf1-KD, but the twohybrid system might not be an ideal method to detect such an interaction, and additional
biochemical experiments will be required.
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Fig. 11. Por1 interacts with Snf1-KD in the two-hybrid system. Transformants of the reporter strain CTY
10-5d with integrated lexAop-lacZ expressing the indicated protein pairs were grown to mid-log phase in
selective medium with high glucose (2%), and then for 3h shift to an otherwise identical medium with low
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Por1 interact
in the yeast
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in high andcells
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of
glucoseand
(0.05%).
β-Galactosidase
activity
was assayed
in permeabilized
expressed
in MillerTransformants
units.
Values are averages for at least four transformants. Error bars indicate standard error. Asterisks indicate
strainstatistically
CTY10-5dsignificant
with an integrated
lexAop-lacZ
reporter expressing
indicated
were grown to middifference from
the corresponding
controls (p <the
0.001
both inprotein
high andpairs
low glucose).

Fig. 11. Two-hybrid analysis of the interaction between Por1 and the Snf1 kinase domain. The Snf1 kinase domain

log phase in selective medium with high glucose (2%), and then shifted for 3h to an otherwise identical medium
with low glucose (0.05%). β-Galactosidase activity was assayed in permeabilized cells and expressed in Miller units
(U). Values are averages for at least four transformants. Error bars indicate standard errors. Asterisks indicate
statistically significant difference from the corresponding vector controls (p < 0.001 both in high and low glucose).
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Por1 and Por2 function downstream of Hxk2 in regulating the catalytic activation of Snf1
S. cerevisiae encodes three enzymes (Hxk1, Hxk2, and Glk1) that can catalyze the first
step of glycolysis – phosphorylation of glucose to glucose-6-phosphate. In the presence of
abundant glucose, Hxk2 plays the major role in glucose phosphorylation and also makes a
significant contribution to glucose repression (MORENO AND HERRERO 2002). Lack of Hxk2
causes constitutive expression of many Snf1-dependent genes that are normally glucoserepressed, including SUC2 and GAL genes (NEIGEBORN AND CARLSON 1984; GANCEDO 1998)
(see Fig. 12B below). Hxk2 is an upstream negative regulator of Snf1, and glucose-repressible
genes are no longer constitutive in the hxk2 snf1 double mutant (NEIGEBORN AND CARLSON
1984). In cells lacking Hxk2, Snf1 is in the active conformation even in the presence of abundant
glucose (JIANG AND CARLSON 1996), and is constitutively phosphorylated at Thr210 (Fig. 12A).

Fig. 12. Role of hexokinase-2 in the negative control of Snf1. (A) Wild-type cells and cells lacking hexokinase-2
(hxk2∆) were grown to mid-log phase in YEP containing abundant (2%) glucose, and the Thr210 phosphorylation
status (PT210) and total levels of Snf1 were analyzed by immnoblottingas described in Materials and Methods. (B)
Cells of the indicated genotypes with an integrated SUC2-LEU2-lacZ reporter were grown to mid-log phase in YEP
with 2% glucose. β-Galactosidase activity was assayed in permeabilized cells and expressed in Miller units (U).
Values are averages for ten to twelve assays. Error bars indicate standard errors. Reporter expression in the hxk2∆
mutant was statistically significantly different from the wild type (p < 0.001).
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We hypothesized that Hxk2 represses Snf1 by inhibiting Por1 and Por2. To test this
hypothesis, we created a series of mutants including hxk2∆ por1∆, hxk2∆ por2∆, and hxk2∆
por1∆ por2∆ and examined Thr210 phosphorylation in each of these mutants by immunoblotting
in the presence of high (2%) and low (0.05%) glucose. In comparison to the hxk2∆ mutant,
which exhibits constitutive Snf1 Thr210 phosphorylation even in the presence of abundant
glucose, the level of Snf1 Thr210 phosphorylation in the hxk2∆ por1∆ por2∆ triple mutant was
reduced to the wild-type level (Fig.13A). Moreover, when cells were shifted to low glucose, the
hxk2∆ por1∆ por2∆ triple mutant exhibited reduced Thr210 phosphorylation similar to the por1∆
por2∆ double mutant (Fig. 13B). No such reduction was observed in hxk2∆ por1∆ or hxk2∆
por2∆ double mutants.

Fig. 13. Functional relationship between mitochondrial porins and hexokinase-2. Por1 and Por2 function
downstream of hexokinase-2 (Hxk2) in the catalytic activation of Snf1. (A) Cells of the indicated genotypes were
grown to mid-log phase in YEP containing 2% glucose (high glucose). (B) Cells grown in panel A were shifted for
1h to YEP containing 0.05% glucose (low glucose). Thr-210 phosphorylation (PT210) status and total levels of Snf1
were analyzed by immnoblotting as described in Materials and Methods. (C) Cells of the indicated genotypes
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carrying an integrated SUC2-LEU2-lacZ reporter were grown to mid-log phase in YEP with high glucose (2%) and
then shifted to an otherwise identical medium containing low glucose (0.05%). β-Galactosidase activity was assayed
in permeabilized cells and expressed in Miller units (U). Values are averages for four to six assays. Error bars
indicate standard errors. Reporter expression in the hxk2∆ por1∆ por2∆ mutant was statistically significantly
different from the hxk2∆ mutant under high glucose (p < 0.001) and low glucose (p < 0.01) conditions.

Thus, the por1∆ por2∆ double mutation is epistatic to the hxk2∆ mutation in the catalytic
activation of Snf1. These results strongly suggest that Por1 and Por2 function downstream of
Hxk2 in the regulation of Snf1.
We also examined the effects of the mutations on the expression of a Snf1-dependent
reporter SUC2-LEU2-lacZ (SAROKIN AND CARLSON 1985). Under glucose-rich and glucoselimiting conditions, reporter expression was reduced in the hxk2∆ por1∆ por2∆ triple mutant
relative to the hxk2∆ single mutant (Fig. 13C). These results are consistent with the above results
for Thr210 phosphorylation. We note that the partial constitutivity of SUC2-LEU2-lacZ reporter
expression in the triple hxk2∆ por1∆ por2∆ mutant could be attributed to a recently discovered
Snf1-independent, glucose-induced stimulatory effect of Hxk2 on Mig1, a major transcriptional
repressor of the SUC2 promoter (VEGA et al. 2016). In other words, while the hxk2∆ mutation
cannot bypass the requirement of Por1 and Por2 for Snf1 catalytic activation, it could partially
relieve Mig1-mediated repression of SUC2 by an independent mechanism.
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Discussion
The highly conserved mammalian AMPK and yeast Snf1 protein kinases play essential
roles in sensing and regulating the cellular response to changes in glucose/energy levels (HARDIE
2007; HEDBACKER AND CARLSON 2008). Although it is known that binding of AMP to AMPK
leads to its activation, the signal that activates Snf1 has eluded identification for many years, as unlike AMPK - Snf1 is not regulated by AMP (WILSON et al. 1996; HARDIE et al. 1998; ADAMS
et al. 2004). Recent studies demonstrate that ADP binds to the γ subunit Snf4, and protects Snf1
from dephosphorylation by phosphatases in vitro (CHANDRASHEKARAPPA et al. 2011; MAYER et
al. 2011). However, the physiological relevance of this mechanism remains uncertain. First, the
above in-vitro experiments indicate that Snf1 complex responds to absolute ADP levels, but
according to an earlier study, absolute ADP levels remain relatively unchanged between highand low-glucose conditions (WILSON et al. 1996). Second, previous experiments showed that
Snf1 activity in vivo correlates with AMP:ATP ratios, suggesting the existence of another
sensing mechanism that functions in addition or instead of ADP sensing by Snf4.
Our results presented in Chapter 2 and in this study provide a framework that could
accommodate both the Snf4-mediated sensing as well as suggest Snf4-independent mechanisms.
The ability to interact with the VDAC proteins and proximity to the mitochondrial surface could
put the Snf1 complex in a better position to sense glucose/energy limitation via Snf4 as ADP
levels could change more sharply at the mitochondrial surface. Here, we show that the lack of
Por1 and Por2 causes reduced Thr210 phosphorylation of Snf1-KD (Fig. 10), which is unable to
interact with Snf4 (or the β subunits), supporting a role of Por1/Por2 in a Snf4-independent
sensing mechanism, which could explain why Snf1 remains glucose-regulated even in the
absence of Snf4 (MCCARTNEY AND SCHMIDT 2001).
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The ability of some transporters (or transporter homologs) to participate in sensing has
been well established; such transporters/sensors are often referred to as “transceptors” (KRIEL et
al. 2011). In some cases, a transceptor may have retained its transporter function, while in
others, the transporter function has been lost. For example, the Mep2 protein of yeast doubles
both as an ammonium transporter and an ammonium sensor (LORENZ AND HEITMAN 1998). By
contrast, the yeast Snf3 and Rgt2 glucose sensors no longer transport glucose, but simply
represent homologs of glucose transporters (ROLLAND et al. 2002). The common theme is that
transceptors sense what they transport (or used to transport). From this perspective, what could
Por1 and Por2 sense? VDACs have a large repertoire of metabolites for which they serve as
channels, and therefore they could potentially sense multiple signals. The most obvious and
relevant candidates for signaling molecules sensed by VDACs are nucleotides involved in energy
metabolism, such as AMP, ADP, ATP, NADH, etc. Besides small metabolites, protein binding
to VDACs has been shown to affect their conformation. An interesting and relevant example is
offered by highly-glycolytic cancer cells exhibiting the so-called “Warburg” effect. Specifically,
such cells overexpress hexokinase II, which binds to the VDAC proteins and causes their
conversion to the closed state (LEMASTERS AND HOLMUHAMEDOV 2006). Previous experiments
in yeast failed to detect a physical interaction between Hxk2 and Por1 (AFLALO AND AZOULAY
1998). However, we reasoned that despite the lack of a physical interaction, there could still be a
functional relationship. This relationship seemed even more likely given that Hxk2 is known to
negatively regulate Snf1 (JIANG AND CARLSON 1996). Indeed, in this study we have obtained
strong evidence that Por1 and Por2 function downstream of Hxk2 in the Snf1 pathway (Fig. 12),
specifically, that Por1 and Por2 are negatively regulated by Hxk2. If Hxk2 does not physically
bind to the VDAC proteins in yeast, it is logical to assume that the negative regulation occurs via
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a glucose metabolite. It has long been hypothesized that one of the Snf1-inhibiting signals is
glucose-6-phosphate (HEDBACKER AND CARLSON 2008). The glucose analog 2-deoxyglucose
(2DG), which is not metabolized but can be phosphorylated, can mimic glucose repression and
inhibit Snf1 in vivo (FRIIS et al. 2014). The hxk2 mutation allows growth on alternative carbon
sources, e.g. sucrose, despite the presence of 2DG (NEIGEBORN AND CARLSON 1987). Previous
experiments have shown that glucose-6-phosphate does not regulate Snf1 in vitro (WILSON et al.
1996), suggesting the existence of an additional in-vivo sensor of this metabolite in the Snf1
pathway. In this regard, it is interesting that our BLAST searches conducted with relaxed
stringency identified a region of homology between Por1/2 and the Rgt2/Snf3 transporter-like
glucose sensors (Fig. 14A). It was recently reported that this particular region of sugar
transporters is responsible for sugar selectivity (Fig. 14B) (FARWICK et al. 2014). Collectively,
these considerations raise the possibility that one of the metabolites sensed by Por1 and Por2 is
glucose-6-phosphate. We note that we do not think of glucose-6-phosphate as an exclusive
metabolite sensed by the VDACs; in fact, we think it likely that nucleotides can be sensed also,
since evidence indicates that mammalian VDAC has binding sites for AMP, ADP, and ATP
(YEHEZKEL et al. 2006).
B

A

POR1
POR2
RGT2
SNF3

IVGGAEFGYDISA
FVGGTDIAYDTAA
AVGGFLFGYDTGL
AVGGFLFGYDTGL

Fig. 14. Sequence analysis of Por1 and Por2. (A) Putative sugar selectivity box (outlined in red) in Por1, Por2, and
the transporter-like glucose sensors Rgt2 and Snf3. (B) Conserved sugar selectivity box (outlined in red) in sugar
transporters from different species (reproduced from (FARWICK et al. 2014)).
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Further experiments will be required to address the possible role of glucose-6-phosphate
and other molecules such as sugar metabolites or nucleotides as signaling molecules sensed by
Por1 and Por2 to regulate Snf1.

Table 2. S. cerevisiae strains

2

Strain

Genotype

Source

CTY10-5d

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

R. Sternglanz

MMY25

MATa/MATα his3–11,15/his3–11,15 leu2–3,112/leu2–

This laboratory

3,112 trp1–1/trp1–1 ura3–1/ura3–1
CGY5

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

SNF1::snf11-309
CGY6

MATα his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

SNF1::snf11-309
CGY17

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

por1Δ::KanMX6 por2Δ:: KanMX6 SNF1::snf11-309
AMS132

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

hxk2Δ::HisMX6
AMS161

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

hxk2Δ::HisMX6 por1Δ:: KanMX6
AMS164

MATα his3–11,15 leu2–3,112 trp1–1 ura3–1
hxk2Δ::HisMX6 por2Δ:: KanMX6
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This study

AMS170

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

hxk2Δ::HisMX6 por1Δ:: KanMX6 por2Δ:: KanMX6
AMS47

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 por1Δ::

This study

KanMX6 por2Δ:: KanMX6
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Chapter 4
Mitochondrial porins, Por1 and Por2, positively regulate Snf1-Gal83 nuclear localization in
Saccharomyces cerevisiae

Abstract
Members of the Snf1/AMP-activated protein kinase (AMPK) family play a crucial role in
sensing and responding to energy stress in eukaryotes. Snf1/AMPK kinases are activated by
phosphorylation of their activation-loop threonine, and regulate transcription of genes and
activities of metabolic enzymes, to help the cells adapt during energy/glucose limitation. As
described in Chapters 2 and 3, we found a novel role of the mitochondrial voltage-dependent
anion channel (VDAC) proteins Por1 and Por2 in Snf1 catalytic activation in Saccharomyces
cerevisiae. Here, we present evidence that Por1 also positively regulates Snf1 nuclear
localization, and that this effect is exerted via the regulation of the Snf1 nuclear-targeting
subunit, Gal83. We show that Por1 interacts with Gal83 in the yeast two-hybrid system,
suggesting that Por1 plays a role in physically recruiting Gal83 to the nucleus. Further,
overexpression of Por2 in the por1∆ mutant compensates for the Snf1/Gal83 nuclear localization
defect, supporting a physical mass action mechanism. Thus, Por1 and Por2 participate in the
regulation of the Snf1 pathway in more than one way: not only do they promote Snf1 catalytic
activation, but they also positively regulate Snf1-Gal83 nuclear enrichment.

Introduction
Snf1 is the yeast homolog of mammalian AMP-activated protein kinase (AMPK)
(HARDIE et al. 1998; HEDBACKER AND CARLSON 2008). Yeast cells prefer glucose as their
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carbon/energy source, and Snf1 is essential for the growth on alternative carbon sources
(CARLSON et al. 1981; CELENZA AND CARLSON 1986). The Snf1 kinase complex is a heterotrimer
consisting of the catalytic α subunit (Snf1), one of the three alternate targeting/scaffolding β
subunits (Sip1, Sip2, Gal83), and the regulatory γ subunit (Snf4) (HEDBACKER AND CARLSON
2008). Upstream kinases activate Snf1 during energy/glucose limitation by phosphorylating a
conserved Thr210 residue present in the activation-loop of the catalytic α subunit (MCCARTNEY
AND SCHMIDT

2001; HONG et al. 2003; SUTHERLAND et al. 2003). Thr210 dephosphorylation and

Snf1 inactivation primarily involves type 1 protein phosphatase Glc7 in association with
regulatory proteins Reg1 and Reg2 (TU AND CARLSON 1994; TU AND CARLSON 1995;
MCCARTNEY AND SCHMIDT 2001; MAZIARZ et al. 2016), but roles for other two phosphatases
(Sit4 and Ptc1) have also been demonstrated (RUIZ et al. 2011; RUIZ et al. 2013).
Because there are three different β subunits (Sip1, Sip2, Gal83), there are three distinct
isoforms of the Snf1 kinase complex (HEDBACKER AND CARLSON 2008). We will refer to these
isoforms as Snf1-Sip1, Snf1-Sip2, and Snf1-Gal83 (i.e. skipping Snf4 for the sake of brevity). In
abundant glucose, all three isoforms are cytoplasmic. During glucose starvation, all three
isoforms are catalytically activated, and show distinct subcellular localization: Snf1-Sip1 is
targeted to the vacuolar membrane, Snf1-Sip2 remains cytoplasmic, and Snf1-Gal83 enriches in
the nucleus to promote transcription of genes involved in the utilization of alternate carbon
sources and respiration (HEDBACKER AND CARLSON 2008).
We have previously shown that normal Snf1 catalytic activation in response to low
glucose depends on the voltage-dependent anion channel (VDAC) proteins Por1 and Por2 (see
Chapter 2). VDACs are highly conserved in evolution and are located in the mitochondrial outer
membrane (COLOMBINI 2004; COLOMBINI AND MANNELLA 2012). VDACs allow exchange of
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small metabolites between the cytoplasm and the mitochondria, and also play a major role in
respiration and apoptosis (COLOMBINI 2004; COLOMBINI AND MANNELLA 2012).
In this chapter, we show that Por1 positively regulates Snf1 nuclear localization, and that
this effect is exerted via the regulation of the Snf1 nuclear-targeting subunit, Gal83. We show
that Por1 interacts with Gal83 in the yeast two-hybrid system, suggesting that Por1 plays a role
in physically recruiting Gal83 to the nucleus. Further, overexpression of Por2 in the por1∆
mutant compensates for the Snf1-Gal83 nuclear localization defect, supporting a physical mass
action mechanism. Thus, Por1 and Por2 participate in the regulation of the Snf1 pathway in more
than one way: not only do they promote Snf1 catalytic activation, but they also positively
regulate Snf1-Gal83 nuclear enrichment.

Materials and Methods
Strains and growth conditions. The S. cerevisiae strains used in this study are listed in Table 3.
Strain CTY10-5d (MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1-901) (R.
Sternglanz, SUNY, Stony Brook, NY) and its por1∆, por2∆, gal83∆, and por1∆ gal83∆
derivatives used to perform LexA-Snf1-G53R reporter activation assays. All other strains used
for microscopy and spotting growth assays were in the W303 background. To generate the
por1∆::KanMX6, por2∆::KanMX6, gal83∆::KanMX6, and snf1∆::KanMX6 alleles, the marker
sequences were amplified by PCR with primers flanking the corresponding open reading frames.
The mutant alleles were introduced into CTY10-5d and W303 strains by transformation; all yeast
transformations were performed using standard methods (ROSE et al. 1990). The genotypes of all
knock-out strains were confirmed by PCR analysis of genomic DNA. Double mutants lacking
Snf1 and either Por1 or Por2 were constructed by tetrad analysis of diploid cells obtained by
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crossing snf1∆ and either por1∆ or por2∆ mutants of the opposite mating types. Similarly, por1∆
gal83∆ double mutants were generated by crossing por1∆ and gal83∆ single mutants, followed
by tetrad analysis.
Rich medium was yeast extract-peptone (YEP) supplemented with extra tryptophan (40
mg/liter) and adenine (20 mg/liter); synthetic complete (SC) medium lacking appropriate
supplements was used to select for plasmids (ROSE et al. 1990). Unless indicated otherwise, the
media contained 2% glucose, and cells were grown at 30°C.

Plasmid construction. Plasmid pSnf1-GFP expresses a Snf1-GFP fusion from the native SNF1
promoter in low-copy-number CEN-URA3 vector pRS316 (SIKORSKI AND HIETER 1989), and
was constructed essentially as described previously (VINCENT et al. 2001). The multicopy vector
pSK71 with the TRP1 selectable marker provides expression from ADH1 promoter and was
derived from pBTM116 (FIELDS AND SONG 1989) by deleting the LexA-encoding sequence.
Plasmid pAMS10 overexpresses Por2-V5 from vector pSK71, and was constructed as follows.
The POR2 gene was amplified by PCR using wild-type genomic DNA as the template; the long
103 nt reverse primer for this PCR also included a sequence encoding a flexible amino acid
linker (SABOURIN et al. 2007) consisting of two Gly-Gly-Ser-Gly repeats followed by the V5 tag.
The resulting fragment was cloned into the BamHI site of pSK71. Functionality of Por2-V5 was
confirmed by complementation of a por1∆ por2∆ mutant (BLACHLY-DYSON et al. 1997).
Plasmid pAMS11 expresses LexA-Gal83 and was constructed by inserting the GAL83 coding
sequence amplified by PCR from pRT12 (VINCENT et al. 2001) at the BamHI site of vector
pEG202 (GOLEMIS et al. 1997).
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Assays of “shortcut” transcription activation by LexA–Snf1G53R. The principle behind the
“shortcut” reporter activation assays was described previously (KUCHIN et al. 2000). Strain
CTY10–5d carries LexA operator sequences (lexAop) inserted upstream of the lacZ gene
(lexAop-lacZ reporter). Wild-type CTY10-5d and its por1∆, por2∆, gal83∆, and por1∆ gal83∆
mutant derivatives were transformed with plasmid pRJ216 expressing LexA-Snf1-G53R
(KUCHIN et al. 2000); LexA-Snf1-G53R activates the lexAop-lacZ reporter in a glucose-regulated
manner that reflects the catalytic activation of the Snf1-G53R moiety and its nuclear localization
(KUCHIN et al. 2000; VINCENT et al. 2001). The corresponding vector control was pEG202
(GOLEMIS et al. 1997). For testing the effects of Por2-V5 overexpression, reporter strains were
co-transformed with pRJ216 and either pAMS10 or vector pSK71. Transformants were grown to
mid-log phase with plasmid selection in selective SC medium with high (2%) glucose and then
shifted to an otherwise identical medium with low (0.05%) glucose for 3h. β-Galactosidase
activity was assayed in permeabilized cells and expressed in Miller units as described previously
(VYAS et al. 2001).
To confirm expression of the fusion proteins by immunoblotting, transformants were
grown under conditions identical to those used to perform reporter assays. Cell extracts were
prepared using the boiling/alkaline lysis method (ORLOVA et al. 2008). Proteins were separated
by SDS-PAGE and analyzed by immunoblotting. LexA fusion proteins were detected with antiLexA antibody (Millipore). Por2-V5 fusion proteins were detected with anti-V5 antibody
(Thermo Fisher Scientific). Thr210-phosphorylated LexA-Snf1-G53R proteins were detected
with anti-phospho-Thr172-AMPK (Cell Signaling Technology) as described previously
(ORLOVA et al. 2008). Signals were detected by enhanced chemiluminescence using Pierce
ECL2 or HyGlo (Denville Scientific).
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Fluorescence microscopy. For Snf1-GFP and Gal83-GFP localization studies, we followed the
protocol published previously (VINCENT et al. 2001). Briefly, cells expressing Snf1-GFP or
Gal83-GFP were grown to mid-log phase in selective SC containing 2% glucose and then shifted
to an otherwise identical medium containing 3% ethanol and 2% glycerol instead of glucose for
20 min (VINCENT et al. 2001). Nuclei were stained by adding 10 µl of 0.8 µg/mL DAPI to 1 mL
of cell culture and incubating for 5 min at 30°C. The cells were then collected by brief
centrifugation, and the DAPI and GFP signals were examined using a workstation consisting of
Nikon Eclipse 80i fluorescence microscope, a CoolSNAP HQ2 camera (Photometrics), and a
computer with NIS-Elements BR 3.01 software.
Expression of the fusion proteins was confirmed by immunoblotting as follows.
Transformants were grown under conditions identical to those used to perform fluorescence
microscopy. Cell extracts were prepared using the boiling/alkaline lysis method (ORLOVA et al.
2008). Proteins were separated by SDS-PAGE and analyzed by immunoblotting. GFP fusion
proteins were detected with anti-GFP antibody (Roche). Thr210-phosphorylated Snf1 proteins
were detected with anti-phospho-Thr172-AMPK (Cell Signaling Technology) as described
previously (ORLOVA et al. 2008). Signals were detected by enhanced chemiluminescence using
Pierce ECL2 or HyGlo (Denville Scientific).

Results
Transcriptional activation of a reporter by LexA-Snf1G53R is affected in a por1∆ mutant.
In Chapter 2, we have shown that Por1 and Por2 play redundant roles in promoting Snf1
activation/Thr210 phosphorylation (Fig. 9A,B). Interestingly, despite the lack of any obvious
defect in Thr210 phosphorylation, the por1∆ mutation alone conferred a significant defect in the
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expression of the Snf1-dependent reporter SUC2-LEU2-lacZ (Fig. 9C). This suggested that the
por1∆ mutation affects another aspect of Snf1 function that is distinct from Thr210
phosphorylation. To further address this possibility, we turned to the so-called “shortcut”
reporter assay (KUCHIN et al. 2000) that takes advantage of a hyperactive but glucose-regulatable
version of Snf1 (Snf1-G53R). The shortcut assay tests for the ability of Snf1-G53R fused to the
LexA DNA-binding protein (LexA-Snf1-G53R) to activate transcription by binding to the LexA
operator sequences (lexAop) upstream of a lacZ gene (lexAop-lacZ reporter). This allows
stimulation of RNA polymerase II holoenzyme by a mechanism that does not rely on genespecific transcription factors (Fig. 15A). Importantly, activation of the lexAop-lacZ reporter by
LexA-Snf1-G53R is highly glucose regulated: reporter activation is weak under glucose-rich
conditions, but increases dramatically upon glucose limitation in a manner that requires catalytic
activation (Thr210 phosphorylation) of the Snf1-G53R moiety (KUCHIN et al. 2000). In addition
to catalytic activation, lexAop-lacZ reporter activation by LexA-Snf1-G53R is strongly affected
by mechanisms that regulate Snf1 nuclear localization (VINCENT et al. 2001). As such, the
“shortcut” reporter assay represents a sensitive readout for defects in Snf1 catalytic activation
and nuclear localization.
The lexAop-lacZ reporter is widely used for two-hybrid experiments, and strain CTY105d carries a genomically integrated copy of this reporter that can be used for the “shortcut” assay
(KUCHIN et al. 2000). We expressed LexA-Snf1-G53R in wild-type CTY10-5d and its por1∆ and
por2∆ derivatives. Reporter activation was monitored by β-galactosidase assays after growth in
high glucose (2%) and after shift to low glucose (0.05%) for 3h. The por1∆ mutant exhibited a
strong activation defect in low glucose (Fig. 15B). This defect could not be attributed to reduced
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Thr210 phosphorylation of the Snf1-G53R moiety (Fig. 15C,D), suggesting against a defect in
catalytic activation, and instead suggesting a defect in nuclear localization.

Fig. 15. The por1∆ mutation strongly affects lexAop-lacZ reporter activation by LexA-Snf1-G53R. (A) Under
glucose-limiting conditions, hyperactive LexA-Snf1-G53R becomes catalytically activated and enters the nucleus,
where it binds to the promoter of the lexAop-lacZ reporter and stimulates transcription by RNA polymerase II (RNA
Pol II) holoenzyme (modified from (KUCHIN et al. 2000)). (B) CTY10-5d (WT) and its por1∆ and por2∆ mutant
derivatives expressed LexA-Snf1-G53R from plasmid pRJ216. Cells were grown in SC medium with plasmid
selection in the presence of high (2%) glucose to mid-log phase, and then shifted for 3h to an otherwise identical
medium containing low (0.05%) glucose. β-Galactosidase activity was assayed in permeabilized cells and expressed
in Miller units (5-9 independent measurements per datapoint). The graph shows the data for low glucose conditions
expressed as % of the wild type. Under high glucose conditions, all values were < 3% of the wild-type value
observed in low glucose. The mean wild-type value in low glucose was 278 Miller units. Error bars indicate
standard errors. An ANOVA with Tukey's post hoc test indicated that all values were statistically significantly
different from each other (p < 0.0001). (C,D) Transformants shifted to 0.05% glucose for 3h as above were tested
for Thr210 phosphorylation of the Snf1-G53R moiety (PT210) and total LexA-Snf1-G53R protein levels (Total) by
immunoblotting using anti-phospho-Thr172-AMPK and anti-LexA, respectively, as described in Materials and
Methods; vec, vector control pEG202.

67

The por1∆ mutation affects Snf1 nuclear enrichment.
To determine the effects of the por1Δ and por2Δ mutations on Snf1 localization, we
constructed a C-terminally GFP-tagged Snf1 (Snf1-GFP). Snf1-GFP localization was examined
in cells grown in high (2%) glucose and after a shift to an otherwise identical medium with a
mixture of 3% ethanol and 2% glycerol (EG) as the carbon source instead of glucose, following a
previously published protocol (VINCENT et al. 2001). In the presence of abundant glucose, Snf1GFP was excluded from the nucleus in all strains tested (Fig. 16A, B, C; top panels). Upon shift
to EG medium, Snf1-GFP enriched in the nucleus in the wild-type and por2Δ cells (Fig. 16A, C;
bottom panels). However, no nuclear enrichment was observed in por1Δ cells (Fig. 16B, bottom
panel), and this defect could not be attributed to defective activation-loop Thr210
phosphorylation (Fig. 16E). Together, results in Fig. 15 and Fig. 16 strongly suggest that por1∆
affects Snf1 nuclear enrichment by a mechanism that is independent of its catalytic activation.
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Fig. 16. Snf1 does not enrich in the nucleus of a por1∆ mutant. (A-C) Localization of Snf1-GFP (GFP) was
determined by fluorescence microscopy after growth in selective SC containing abundant (2%) glucose (Glu), and
after a shift to an otherwise identical medium containing a mixture of 3% ethanol and 2% glycerol as the carbon
source (EG). Nuclei were stained with DAPI. (D) Brief summary table. (E) Thr210 phosphorylation (PT210) and
total Snf1-GFP protein levels were detected by using anti-phospho-Thr172-AMPK and anti-GFP, respectively; vec,
vector control pRS316.

Por1 positively regulates the nuclear localization of Gal83.
Two lines of reasoning suggested that Por1 could regulate Snf1 nuclear localization by
regulating the nuclear localization of Gal83, one of three alternate β subunits of the Snf1 kinase
complex. First, Gal83 is required for targeting Snf1 to the nucleus (VINCENT et al. 2001).
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Second, our yeast two-hybrid assays suggested that Por1 physically interacts with Gal83 (Fig.
17).
DNA-bound
protein

Activating
protein
GAD

LexA-Gal83

GAD-Por1

***
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LexA-Gal83
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200
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400

500

600

β-Galactosidase activity, U

Fig. 17. Por1 interacts with Gal83 in the two-hybrid system. Cells of strain CTY10-5d with an integrated lexAoplacZ reporter expressing the indicated protein pairs were grown to mid-log phase in selective SC medium containing
high (2%) glucose, and then shifted for 3h shift to an otherwise identical medium containing low (0.05%) glucose.
β-Galactosidase activity was assayed in permeabilized cells and expressed in Miller units (U). Values are averages
for at least four transformants per combination. Error bars indicate standard errors. Although LexA-Gal83 shows an
ability to activate transcription on its own, as reported earlier (LESAGE et al. 1996), co-expression of the GAD-Por1
fusion led to a significant increase in reporter activation relative to the GAD controls (P < 0.001 both in high and
low glucose).
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Fig. 18. Gal83 does not enrich in the nucleus of a por1∆ mutant. (A-C) Localization of Gal83-GFP (GFP) expressed
from pRT12 was determined by fluorescence microscopy after growth in SC-His in the presence of 2% glucose
(Glu), and upon a 20 min shift to an otherwise identical medium containing a mixture of 3% ethanol and 2%
glycerol (EG) as the carbon source. Nuclei were stained with DAPI. (D) Brief summary table. (E) Gal83-GFP
protein levels (Gal83-GFP), as well as Thr210 phosphorylation (PT210) and total levels of Snf1 (Total) were
analyzed by immunoblotting using anti-GFP, anti-phospho-Thr172-AMPK, and anti-polyhistidine antibodies,
respectively.
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We therefore examined the effects of the por1∆ and por2∆ mutations on Gal83
localization, using a previously described Gal83-GFP fusion expressed from plasmid pRT12
(VINCENT et al. 2001). In all cases, Gal83-GFP was excluded from the nucleus of glucosegrown cells (Fig. 18A, B, C; top panels). Upon shift to ethanol-glycerol, Gal83-GFP enriched in
the nuclei of wild-type and por2∆ cells, but not in the por1∆ mutant cells (Fig. 18A, B, C;
bottom panels).
When Gal83 is complexed with Snf1, catalytic activation of the associated Snf1 subunit
is a prerequisite for Snf1-Gal83 nuclear translocation: if Snf1 is not phosphorylated at Thr210, it
will hold Gal83 in the cytoplasm (HEDBACKER et al. 2004). As observed previously,
immunoblot analysis indicated that in the por1∆ mutant Thr210 is phosphorylated at a level
comparable to that in the wild type (Fig. 18E; compare lanes 4 and 6), suggesting that the Gal83
nuclear localization defect is not associated with a Snf1 activation defect.
Catalytic activation of Snf1 is required for Gal83 nuclear localization only when Gal83 is
associated with Snf1; when Gal83 is not associated with Snf1 (e.g. in a snf1∆ mutant), it will
enrich in the nucleus in a Snf1-independent manner (VINCENT et al. 2001; HEDBACKER et al.
2004). To determine whether Por1 regulates this Snf1-independent nuclear localization of Gal83,
we expressed Gal83-GFP in a snf1∆ por1∆ double mutant (see immunoblot in Fig. 18E, lanes 9
and 10) and examined its localization after growth in abundant glucose and following a shift to
ethanol-glycerol. We observed that just as in the por1∆ single mutant, Gal83-GFP did not enrich
in the nucleus in the snf1∆ por1∆ double mutant on ethanol-glycerol (Fig. 19B; bottom panels).
No such defect was observed in the snf1∆ por2∆ double mutant cells (Fig. 19C; bottom panels).
Collectively, these results suggest that the por1∆ mutation affects the nuclear localization of the
Snf1 kinase complex by affecting the nuclear localization of Gal83.
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Fig. 19. Gal83 does not enrich in the nucleus of a snf1∆ por1∆ mutant. (A-C) Localization of Gal83-GFP (GFP)
expressed from pRT12 was determined by fluorescence microscopy after growth in selective SC medium in the
presence of 2% glucose (Glu), and after a shift to an otherwise identical medium containing a mixture of 3% ethanol
and 2% glycerol as the carbon source (EG). Nuclei were stained with DAPI. (D) Brief summary table.

Overexpression of Por2 suppresses the por1∆ mutation for defects in Snf1-Gal83 nuclear
localization and transcriptional activation by LexA-Snf1-G53R.
In Chapter 2, we showed that Por1 and Por2 play redundant roles in Snf1 catalytic
activation (Thr210 phosphorylation). Por2 does not appear to possess channel activity
(BLACHLY-DYSON et al. 1997; LEE et al. 1998), strongly suggesting that Por1/2-mediated
mechanism of Snf1 activation is unrelated to VDAC channel function. Since Snf1-Gal83
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localization is affected only by the por1∆ mutation, but not by the por2∆ mutation, one might
conclude that in this case the VDAC channel function is important. However, previous evidence
also indicates that the Por2 protein is expressed at a six-to-eight-fold lower level than the Por1
protein (BLACHLY-DYSON et al. 1997). Therefore, it remains possible that the differential
requirement of Por1 and Por2 for Snf1-Gal83 nuclear localization reflects the difference in their
expression levels rather than the difference in channel function. To address this possibility, we
tested whether Por2 overexpression can compensate for the Snf1-Gal83 localization defect
caused by the lack of Por1.
We constructed a plasmid (pAMS10) expressing a C-terminally V5-tagged Por2 (Por2V5) from the strong ADH1 promoter of multicopy vector pSK71. Overexpression of Por2-V5
suppressed the por1∆ mutation for both the Snf1 nuclear localization defect (Fig. 20) and the
Gal83 nuclear localization defect (Fig. 21A). We note that overexpression of Por2-V5 did not
restore nuclear enrichment of Gal83-GFP in the snf1∆ por1∆ double mutant (Fig. 21B),
indicating that the ability of overexpressed Por2 to functionally compensate for the lack of Por1
is Snf1-dependent.
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Fig. 20. Overexpression of Por2 suppresses the por1∆ mutation for the Snf1 nuclear localization defect. (A-D) Wildtype (WT) and por1∆ cells expressing Snf1-GFP and either overexpressing Por2-V5, or carrying the corresponding
empty vector, were grown to mid-log phase in selective SC medium containing 2% glucose (Glu) and then shifted to
an otherwise identical medium containing 3% ethanol and 2% glycerol as the carbon source (EG). Nuclei were
stained with DAPI. Localization of Snf1-GFP was determined by fluorescence microscopy. (E) Brief summary
table. (F) Immunoblot analysis of transformants used in panels A-C. The levels of Snf1-GFP phosphorylated at
Thr210 (PT210), total Snf1-GFP (Total), and Por2-V5 were analyzed as described in Materials and Methods. Por2V5 was overexpressed from pAMS10 (Por2-V5, ++), and the corresponding empty vector was pSK71 (Por2-V5, -).
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Fig. 21. Effects of Por2 overexpression on localization of Gal83-GFP. (A,B) Cells of the indicated genotypes
expressing Gal83-GFP and overexpressing Por2-V5 were grown to mid-log phase in selective SC medium
containing 2% glucose (Glu) and then shifted to an otherwise identical medium containing 3% ethanol and 2%
glycerol as the carbon source (EG). Nuclei were stained with DAPI. Localization of Gal83-GFP was determined by
fluorescence microscopy. (C) The levels of Gal83-GFP, phospho-Thr210-Snf1 (PT210), total Snf1 (Total), and
Por2-V5 were analyzed by immunoblotting as described in Materials and Methods. Por2-V5 was overexpressed
from pAMS10 (Por2-V5, ++), and the corresponding empty vector was pSK71 (Por2-V5, -).
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Since the por1∆ mutation causes a significant defect in lexAop-lacZ reporter activation by
LexA-Snf1-G53R, we tested whether Por2 overexpression can suppress this defect. We observed
that overexpression of Por2-V5 in the por1∆ mutant derivative of the lexAop-lacZ reporter strain
CTY10-5D restored transcriptional activation by LexA-Snf1-G53R to the wild-type level (Fig.
22).

Fig. 22. Overexpression of Por2 suppresses the por1∆ mutant defect in transcriptional activation by LexA-Snf1G53R. (A) Reporter strain CTY10-5d (WT) and its por1∆ derivative were transformed with pRJ216 expressing
LexA-Snf1-G53R and either pAMS10, which overexpresses Por2-V5 (Por2-V5, ++), or its parent vector pSK71
(Vec). Cells were grown in selective SC containing abundant (2%) glucose to mid-log phase, and then shifted for 3h
to an otherwise identical medium containing low (0.05%) glucose. β-Galactosidase activity was assayed in
permeabilized cells and expressed in Miller units (4-5 independent measurements per datapoint). The graph shows
the data for low glucose conditions expressed as % of the control value (mean of WT with vector; 347 Miller units).
Under high glucose conditions, all values were < 3% of the low-glucose control value. Error bars indicate standard
errors. According to ANOVA with Tukey’s post-hoc analysis, the value for the por1∆ mutant carrying the empty
vector was significantly lower than that for the wild type with the empty vector (*, p < 0.05); the value for the por1∆
mutant overexpressing Por2-V5 was significantly higher than for the por1∆ mutant carrying the empty vector (**,
p < 0.01). (B) The wild-type and por1∆ transformants shifted to low (0.05%) glucose were tested for Thr210
phosphorylation of the Snf1-G53R moiety (PT210), for total LexA-Snf1-G53R protein levels (Total), and for Por2V5 protein levels by immunoblotting as described in Materials and Methods.
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The ability of LexA-Snf1-G53R to activate transcription of the lexAop-lacZ reporter gene is
completely dependent on Gal83-mediated nuclear localization (VINCENT et al. 2001). If Por2
ovexpression suppresses the por1∆ reporter activation defect by restoring Gal83 nuclear
localization, then the requirement for Gal83 should not be bypassed. We therefore examined the
effects of Por2 overexpression on reporter activation by LexA-Snf1-G53R in gal83∆ and por1∆
gal83∆ mutants. LexA-Snf1-G53R failed to activate transcription in these mutants despite the
overexpression of Por2-V5 (Fig. 23). This provides further support the notion that Por2
overexpression stimulates the nuclear translocation of Gal83.

Fig. 23. Overexpression of Por2 does not bypass the requirement of Gal83 for lexAop-lacZ reporter activation by
LexA-Snf1-G53R. (A) Reporter strain CTY10-5d (WT) and its gal83∆ and por1∆ gal83∆ mutant derivatives with
LexA-Snf1-G53R overexpressing Por2-V5 (Por2-V5, ++), or carrying the corresponding empty vector (Vec), were
grown in selective SC containing high (2%) glucose to mid-log phase, and then shifted for 3h to an otherwise
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identical medium containing low (0.05%) glucose. β-Galactosidase activity was assayed in permeabilized cells and
expressed in Miller units (U). The presented values are averages for four to five transformants assayed under lowglucose conditions. Error bars indicate standard errors. (B) Representative transformants were analyzed by
immunoblotting for Thr210 phosphorylation of the Snf1-G53R moiety (PT210), total LexA-Snf1-G53R protein
levels (Total), and Por2-V5 protein levels under high (H) and low (L) glucose conditions as specified for panel A.
LexA-Snf1-G53R was expressed from pRJ216 (LexA-Snf1-G53R, +); the corresponding vector was pEG202
(LexA-Snf1-G53R, -). Por2-V5 was overexpressed from pAMS10 (Por2-V5, ++); the corresponding empty vector
was pSK71 (Por2-V5, -).

Collectively, these results provide strong evidence that Por1 positively regulates Snf1
nuclear localization (and nuclear activity) by stimulating nuclear enrichment of Gal83. Por2 also
plays a role in this process, but its contribution is minor, presumably reflecting its lower
abundance in comparison with Por1.

Expression of hyperactive LexA-Snf1-G53R restores the ability of the por1∆ mutant to
grow on non-fermentable carbon sources in a Gal83-dependent manner.
In the course of our experiments we noted that expression of hyperactive LexA-Snf1G53R suppresses the por1∆ mutation for defective growth on non-fermentable carbon sources
(3% ethanol plus 2% glycerol) (Fig. 24). This result might be taken to suggest that the primary
cause of the por1∆ mutant growth defect is reduction of overall Snf1 kinase activity in the cell.
However, our previous results (Chapter 2) strongly suggested that the por1∆ mutation does not
lead to a defect in Snf1 catalytic activation (see Fig. 9B). We therefore hypothesized that the
ability of hyperactive LexA-Snf1-G53R to suppress por1∆ reflects not an overall boost of
cellular Snf1 activity, but specifically an increase of Snf1 activity in the nucleus. If so, the ability
of LexA-Snf1-G53R to suppress por1∆ would be expected to depend on Gal83. Indeed,
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expression of LexA-Snf1-G53R failed to restore the growth of a por1∆ gal83∆ double mutant on
ethanol-glycerol (Fig. 24). Thus, one of the reasons for the por1∆ mutant’s growth defect on
non-fermentable carbon sources is likely to be a reduction in nuclear Snf1 activity. We note,
however, that this may not be the only cause, since the gal83∆ mutation, which abolishes Snf1
nuclear localization, does not affect growth on non-fermentable carbon sources (Fig. 24). We
believe that the growth defect of the por1∆ mutant on non-fermentable carbon sources results
from a combination of at least two pleiotropic effects: one being impaired Snf1 nuclear activity,
and another – most likely – reduced permeability of the mitochondrial outer membrane.

Fig. 24. Expression of hyperactive LexA-Snf1-G53R restores the ability of the por1∆ mutant to grow on nonfermentable carbon sources in a Gal83-dependent manner. Serially diluted cell suspensions were spotted onto
selective SC plates with 2% glucose or 3% ethanol + 2% glycerol as carbon sources and grown at 30oC for 2 and 4
days, respectively.
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Discussion
We previously showed that Por1 and Por2 play redundant roles in the positive regulation
of Snf1 catalytic activation (Thr210 phosphorylation). In this study, we present evidence for their
role in promoting the nuclear translocation of the Snf1-Gal83 isoform of the kinase.
The primary location of mitochondrial VDAC/porin proteins is the mitochondrial outer
membrane. However, several lines of evidence suggest that at least some amount of yeast VDAC
can localize to the nucleus. First, a previous subcellular fractionation study, which used porin as
a mitochondrial marker, detected a small amount of this protein in the nuclear fraction
(SCHNEITER et al. 1999). Second, a global study of protein complexes detected Por1 in
association with components of the RNA polymerase II holoenzyme (HO et al. 2002). Third,
protein interactions involving Por1 can be detected using the yeast two-hybrid system, in which
both interaction partners must be present in the nucleus; for example, the biochemically verified
interaction between Snf1 and Por1 was detected in the two-hybrid system using LexA-Por1 or
Gad-Por1 fusion proteins, which were not furnished with any artificial nuclear localization signal
sequences (Chapter 2). Thus, it seems likely that the requirement of Por1 for the nuclear
enrichment of Gal83 is related to its ability to localize to the nucleus.
Por1 is the major VDAC isoform of yeast and is expressed at a six-to-eight fold higher
level than the other VDAC protein, Por2 (BLACHLY-DYSON et al. 1997). Although the lack of
Por2 did not confer any obvious defects in the nuclear localization of Snf1-GFP and Gal83-GFP,
it did lead to a modest reduction in transcriptional activation by LexA-Snf1-G53R. Importantly,
overexpression of Por2 suppressed the por1∆ mutation for the Snf1-Gal83 nuclear localization
defect, indicating that Por2 also plays a minor role. Thus, the relative contributions of Por1 and
Por2 to promoting Snf1-Gal83 nuclear localization most likely reflect their relative abundance,
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suggesting a mass action mechanism. We therefore envision that Por1/2 physically recruit Snf1Gal83 to the nucleus, and this notion is further supported by the two-hybrid interaction between Por1
and Gal83. The recruitment process could be accompanied by formation of a contact site/interface
between the mitochondrial and nuclear surfaces. Further experiments will be required to better
understand the underlying mechanism in more detail.
It is also possible that besides regulating the nuclear localization of Snf1-Gal83, Por1 (and
Por2) could regulate Snf1-Sip1, which is targeted to the vacuolar membrane. This conjecture is
supported by a proteomic study that detected Por1 in a complex with Sip1 (HO et al. 2002) and a
study that detected Por1 in the vacuolar fraction (SCHNEITER et al. 1999).
In yeast, there are three enzymes - Hxk1, Hxk2, and Glk1 - that catalyze the first step of
glycolysis, converting glucose to glucose-6-phosphate. Elimination of Hxk2 causes constitutive
activation of Snf1, indicating that Hxk2 is a negative regulator of Snf1. In Chapter 3, we presented
evidence that Por1 and Por2 function downstream of Hxk2 in the regulation of Snf1catalytic
activation, suggesting that Por1 and Por2 could serve as sensors of a glucose metabolite, most likely
glucose-6-phosphate. This idea was further supported by the presence of a putative sugar selectivity
box in their sequences. The involvement of Por1 (and to a lesser extent, Por2) in regulating the
localization of Snf1-Gal83 elevates the possibility of a connection between the porins and glucose-6phosphate to a higher level. It was previously shown that the glucose analog 2-deoxyglucose (2-DG),
which is phosphorylated but not further metabolized, strongly inhibits the nuclear enrichment of
Gal83 (VINCENT et al. 2001). We propose a unifying model in which Por1 and Por2 play roles in the
regulation of both Snf1 activation and nuclear localization by sensing glucose-6-phosphate.
In summary, Snf1/AMPK and VDAC proteins are highly conserved, and functional
relationships similar to the one described here could exist in other eukaryotes, including humans.
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Table 3. S. cerevisiae strains
Strain

3

Genotype

Source

CTY10-5d

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

R. Sternglanz

YSK1271

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

This lab

por1Δ:: KanMX6
YSK1274

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

This lab

por2Δ:: KanMX6
AMS302

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

This study

gal83Δ:: KanMX6
AMS293

MATa URA3::lexAop-lacZ his3 leu2 ade2 trp1 por1Δ::

This study

KanMX6 gal83Δ:: KanMX6
MMY35

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This lab

YSK1279

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 por1Δ:: KanMX6

This lab

YSK1283

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 por2Δ:: KanMX6

This lab

AMS125

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 snf1Δ:: KanMX6

This study

AMS135

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 snf1Δ:: KanMX6

This study

por1Δ :: KanMX6
AMS140

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 snf1Δ:: KanMX6

This study

por2Δ :: KanMX6
AMS108

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 gal83Δ:: KanMX6

This study

AMS298

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 por1Δ:: KanMX6

This study

gal83Δ:: KanMX6
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Chapter 5
Mitochondrial respiration regulates Snf1 nuclear localization by modulating Snf1-Gal83
complex formation.
Abstract
The Snf1 protein kinase of Saccharomyces cerevisiae is essential for adaptation to glucose
limitation. Previously, we showed that in glucose-limited respiratory deficient rho0 cells lacking
the mitochondrial genome, Snf1is normally activated by phosphorylation of its T-loop threonine
(Thr210). Here, we have observed that despite being activated, Snf1 does not enrich in the
nucleus. Interestingly, the nuclear-targeting β subunit Gal83 does not show such a localization
defect, suggesting that it is not associated with the Snf1 kinase complex. We present evidence
that rho0 cells overexpress Sip2, the cytoplasmic β subunit. Furthermore, Snf1 nuclear
localization in rho0 cells can be restored by elimination of Sip2. These results suggest a model in
which respiratory deficiency causes a redistribution of Snf1 isoforms in favor of the cytoplasmic
Snf1-Sip2 complex at the exclusion of the nuclear Snf1-Gal83 complex. The biological
significance of this mechanism could be to reduce the expression of genes involved in the
utilization of non-fermentable carbon sources and respiration when the mitochondrial respiratory
function is entirely unavailable.

Introduction
Mitochondria have diverse functions including ATP production, generation of
metabolites for cellular processes, and contributions to autophagy, apoptosis, and aging
(WALLACE et al. 2010; NUNNARI AND SUOMALAINEN 2012). Mitochondria arose from
prokaryotes and have their own circular genome, although most proteins required for
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mitochondrial structure and function are encoded in the nucleus (LANE AND MARTIN 2010).
Mutations in the mitochondrial genome and nuclear genes required for mitochondrial function
have been implicated in many neurodegenerative diseases, cancer, and obesity (SCHAEFER et al.
2008; WALLACE et al. 2010; GREAVES et al. 2012). A better understanding of diseases caused by
mitochondrial dysfunction could suggest novel therapeutic approaches. Since mitochondria play
a crucial role in maintaining energy homeostasis, it is important to study mitochondrial signaling
and the effects of mitochondrial dysfunction on energy-dependent cellular processes.
The Snf1/AMP-activated protein kinase (AMPK) pathway of eukaryotes plays a central
role during response to energy stress (HEDBACKER AND CARLSON 2008; HARDIE et al. 2012).
Mammalian AMPK senses energy depletion (increased AMP:ATP ratios) and - in response stimulates catabolic processes to increase ATP production and inhibits anabolic processes to
reduce ATP consumption (HARDIE AND HAWLEY 2001; HARDIE 2008; HARDIE 2011). AMPK
plays an important role in the biogenesis and maintenance of mitochondria (EGAN et al. 2011;
O'NEILL et al. 2011) and in mitochondrial respiration (MERRILL et al. 1997; WINDER et al. 2000).
Defects in the AMPK pathway could lead to type 2 diabetes, obesity, and cancer (HARDIE 2007;
FOGARTY AND HARDIE 2009; OAKHILL et al. 2011). The AMPK pathway is an important drug
target. For example, metformin, a drug used to treat type 2 diabetes, activates AMPK by
inhibiting mitochondrial ATP production (HARDIE et al. 2012).
AMPK of the yeast Saccharomyces cerevisiae is known as Snf1 (HARDIE et al. 1998;
HEDBACKER AND CARLSON 2008). Yeast cells prefer glucose as their carbon/energy source, and
Snf1 regulates responses to glucose limitation. Snf1 is essential for the utilization of alternative
carbon sources and mitochondrial respiration. When glucose is limiting, Snf1 is activated by
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phosphorylation of the conserved T-loop threonine residue (Thr210), which is performed by
upstream kinases (Sak1, Tos3, Elm1).
Like AMPK, the Snf1 kinase is a heterotrimeric complex consisting of a catalytic α
subunit (Snf1), a scaffolding/targeting β subunit (Sip1, Sip2, or Gal83), and a regulatory γ
subunit (Snf4) (HEDBACKER AND CARLSON 2008). The three alternative β subunits define three
distinct Snf1 complexes, referred to as Snf1-Sip1, Snf1-Sip2, and Snf1-Gal83. In the presence of
abundant glucose, all three complexes are cytoplasmic. Under carbon stress conditions, Snf1Sip1 localizes to the vacuolar membrane, Snf1-Sip2 remains cytoplasmic, and Snf1-Gal83
enriches in the nucleus to regulate transcription (HEDBACKER AND CARLSON 2008).
The mechanisms that regulate the subcellular localization of the Snf1 kinase are not
completely understood, and virtually nothing is known about the possible role of mitochondria in
this process. In the previous chapter, we showed that the mitochondrial outer membrane voltagedependent anion channel (VDAC) proteins, Por1 and Por2, positively regulate Snf1-Gal83
nuclear localization. Here, we present evidence for another mechanism. Specifically, in
respiratory deficient rho0 cells, Snf1 does not enrich in the nucleus. Interestingly, the Gal83
subunit does not show such a localization defect, suggesting that it is not associated with the
Snf1 kinase complex. We show that rho0 cells overexpress Sip2, the cytoplasmic β subunit.
Furthermore, Snf1 nuclear localization in rho0 cells can be restored by deletion of the SIP2 gene.
These results suggest a model in which respiratory deficiency causes a redistribution of Snf1
isoforms in favor of the cytoplasmic Snf1-Sip2 complex at the exclusion of the nuclear Snf1Gal83 complex.
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Materials and Methods
Yeast strains and media. The S. cerevisiae strains used in this study are listed in Table 4.
Except for strain CTY10-5d (R. Sternglanz, SUNY, Stony Brook, NY) and its rho0 derivative
used for LexA-Snf1-G53R reporter assays, all strains were in the W303 genetic background. To
generate sip1∆ mutants, the KanMX6 marker sequence was amplified by PCR with primers
flanking the SIP1 open reading frame (ORF). The mutant allele was first introduced into a wildtype diploid by transformation; all yeast transformations were performed using the standard
lithium acetate method (ROSE et al. 1990). The genotype of the heterozygous
SIP1/sip1∆::KanMX6 diploid was confirmed by PCR analysis of genomic DNA, and haploid
sip1∆::KanMX6 segregants were generated from the heterozygous diploid by tetrad analysis. The
sip2∆ mutants were constructed in the same way. The rho0 mutants were obtained by ethidium
bromide treatment (GOLDRING et al. 1970).
Rich medium was yeast extract-peptone (YEP) supplemented with extra tryptophan (40
mg/liter) and adenine (20 mg/liter); synthetic complete (SC) medium lacking appropriate
supplements was used to select for plasmids (ROSE et al. 1990). Unless indicated otherwise, the
media contained 2% glucose, and cells were grown at 30°C.

Plasmids. Plasmid pSnf1-GFP expresses a Snf1-GFP fusion protein from the native SNF1
promoter and was constructed in low-copy-number CEN-URA3 vector pRS316 (SIKORSKI AND
HIETER 1989) essentially as described previously (VINCENT et al. 2001).
Plasmid pTM2 expresses a Sip2-GFP fusion protein from the native SIP2 promoter and
was constructed in low-copy-number CEN-URA3 vector pRS316 (SIKORSKI AND HIETER 1989)
as follows. The first DNA fragment (fragment A) containing the SIP2 ORF and 0.6 kb of its
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upstream regulatory sequence was amplified by PCR using genomic DNA as the template; the
forward primer for this reaction contained an XbaI site for subsequent insertion into pRS316; the
reverse primer contained a BspEI site for subsequent insertion of the GFP-encoding sequence,
which was followed by a stop codon and a NotI site. The second DNA fragment (fragment B)
represented 0.38 kb of the SIP2 terminator sequence and was amplified by PCR using yeast
genomic DNA as template; the forward primer for this reaction contained a NotI site for
subsequent ligation with fragment A; the reverse primer contained an XbaI site for subsequent
insertion into pRS316. Fragments A and B were digested with NotI and ligated together
(fragment AB), followed by PCR amplification. Fragment AB was digested with XbaI and
inserted into the XbaI site of pRS316, resulting in plasmid pRS316-Sip2. This plasmid was then
digested with BspEI, followed by insertion of a BspEI-flanked PCR fragment encoding GFP,
resulting in plasmid pTM2. Plasmids pRS316-Sip2 and pTM2 complemented a sip1∆ sip2∆
gal83∆ triple mutant (ORLOVA et al. 2006) for the growth defect on glycerol (SCHMIDT AND
MCCARTNEY 2000).

Assays of transcriptional activation by LexA–Snf1G53R. The principle behind the “shortcut”
reporter activation assays was described previously (KUCHIN et al. 2000). Strain CTY10–5d
carries LexA operator sequences (lexAop) inserted upstream of the lacZ gene (lexAop-lacZ
reporter). Wild-type CTY10-5d and its rho0 derivatives were transformed with plasmid pRJ216
expressing LexA-Snf1-G53R (KUCHIN et al. 2000); LexA-Snf1-G53R activates the lexAop-lacZ
reporter in a glucose-regulated manner that reflects the catalytic activation of the Snf1-G53R
moiety and its nuclear localization (KUCHIN et al. 2000; VINCENT et al. 2001). The
corresponding vector control was pEG202 (GOLEMIS et al. 1997). Transformants were grown to
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mid-log phase with plasmid selection in selective SC medium with high (2%) glucose and then
shifted to an otherwise identical medium with low (0.05%) glucose for 3h. β-Galactosidase
activity was assayed in permeabilized cells and expressed in Miller units as described previously
(VYAS et al. 2001).

Fluorescence microscopy. To study Snf1-GFP and Gal83-GFP localization, we followed the
protocol published previously (VINCENT et al. 2001). Briefly, cells expressing Snf1-GFP or
Gal83-GFP were grown to mid-log phase in selective SC containing 2% glucose and then shifted
to an otherwise identical medium containing 3% ethanol and 2% glycerol for 20 min (VINCENT
et al. 2001). Nuclei were stained by adding 10 µl of 0.8 µg/mL DAPI to 1 mL of cell culture and
incubating for 5 min at 30°C. The cells were then collected by brief centrifugation, and the DAPI
and GFP signals were examined using a workstation consisting of Nikon Eclipse 80i
fluorescence microscope, a CoolSNAP HQ2 camera (Photometrics), and a computer with NISElements BR 3.01 software.

Immunoblotting. Cells were grown as specified in the text. Protein extracts were prepared using
the boiling/alkaline lysis method (ORLOVA et al. 2008) and examined for the presence of Snf1 by
using anti-polyhistidine antibody H1029 (Sigma-Aldrich), which strongly recognizes Snf1 due to
the presence of a natural stretch of 13 consecutive histidines near its N terminus (amino acids 1830) (ORLOVA et al. 2008). Thr210 phosphorylation of Snf1 was determined using anti-phosphoThr172-AMPK antibody (Cell Signaling Technology) as described previously (ORLOVA et al.
2008). GFP fusion proteins were detected with anti-GFP antibody (Roche). LexA-Snf1-G53R
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protein levels were detected using anti-LexA antibody (Millipore). Signals were detected by
enhanced chemiluminescence using Pierce ECL2 or HyGlo (Denville Scientific).

Results
The rho0 mutation affects transcriptional activation by LexA-Snf1-G53R.
In Chapter 2, we showed that despite the lack of any obvious defect in Thr210
phosphorylation, the rho0 mutation (lack of mitochondrial genome) confers a significant defect
in the expression of a Snf1-dependent reporter, SUC2-LEU2-lacZ (see Fig. 9). This suggested
that the rho0 mutation affects another aspect of Snf1 function that is distinct from Thr210
phosphorylation. To further address this possibility, we turned to the so-called “shortcut”
reporter assay (KUCHIN et al. 2000). This assay tests for the ability of LexA-Snf1-G53R (Gly53to-Arg), a hyperactive but glucose-regulatable version of Snf1 fused to the LexA DNA-binding
protein, to activate transcription by binding to the LexA operator sequences (lexAop) inserted
upstream of the lacZ gene (lexAop-lacZ reporter) and stimulating RNA polymerase II
holoenzyme by a mechanism that does not rely on gene-specific transcription factors (Fig. 25A).
Importantly, activation of the lexAop-lacZ reporter by LexA-Snf1-G53R is highly glucose
regulated: reporter activation is weak under glucose-rich conditions, but increases dramatically
upon glucose limitation in a manner that requires catalytic activation (Thr210 phosphorylation)
of the Snf1-G53R moiety (KUCHIN et al. 2000). In addition to catalytic activation, lexAop-lacZ
reporter activation by LexA-Snf1-G53R is strongly affected by mechanisms that regulate Snf1
nuclear localization (VINCENT et al. 2001). As such, the “shortcut” reporter assay represents a
sensitive readout for defects in Snf1 catalytic activation and nuclear localization.
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The lexAop-lacZ reporter is widely used for two-hybrid experiments, and strain CTY10-5d
carries a genomically integrated copy of this reporter that can be used for the “shortcut” assay
(KUCHIN et al. 2000). We expressed LexA-Snf1-G53R in wild-type CTY10-5d and its rho0
derivative. Reporter activation was examined by β-galactosidase assays after growth in high
glucose (2%) and after shift to low glucose (0.05%) for 3h. The rho0 mutant exhibited a strong
activation defect in low glucose (Fig. 25B). This defect could not be attributed to reduced
Thr210 phosphorylation of the Snf1-G53R moiety (Fig. 25C), suggesting against a defect in
catalytic activation, and instead suggesting a defect in nuclear localization.
B
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Fig. 25. Effect of the rho0 mutation on "shortcut" reporter activation. The rho0 mutation strongly affects the ability
of LexA-Snf1-G53R to activate a lexAop-lacZ reporter. (A) Under glucose-limiting conditions, hyperactive LexASnf1-G53R becomes catalytically activated and enters the nucleus, where it binds to the promoter of the lexAop-lacZ
reporter and stimulates transcription by RNA polymerase II holoenzyme (RNA Pol II) (modified from (KUCHIN et
al. 2000)). (B) Strain CTY10-5d (WT) and its rho0 derivative expressed LexA-Snf1-G53R from plasmid pRJ216.
Cells were grown in selective SC medium containing high (2%) glucose to mid-log phase, and then shifted for 3h to
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an otherwise identical medium containing low (0.05%) glucose. β-Galactosidase activity was assayed in
permeabilized cells and measured in Miller units. The graph shows the data for the low glucose conditions expressed
as % of the wild type. Under high glucose conditions, all values were < 3% of the wild-type value observed in low
glucose. The mean wild-type value in low glucose was 153 Miller units. Error bars indicate standard errors.
Asterisks indicate that β-galactosidase activity in rho0 cells was statistically significantly different from that in the
wild-type cells (p = 0.004, as determined by a t-test). (C) Transformants shifted to 0.05% glucose for 3h as above
were tested for Thr210 phosphorylation of the Snf1-G53R moiety (PT210) and total LexA-Snf1-G53R protein levels
(Total) by immunoblotting using anti-phospho-Thr172-AMPK and anti-LexA, respectively, as described in
Materials and Methods. Vec, vector control pEG202.

The rho0 mutation affects nuclear enrichment of Snf1, but not of Gal83.
To determine the effects of rho0 on Snf1 nuclear localization, we determined Snf1-GFP
localization in cells grown in high (2%) glucose and after a 20 min shift to an otherwise identical
medium with a mixture of 3% ethanol and 2% glycerol (EG) as the carbon source. In the
presence of abundant glucose, Snf1-GFP was excluded from the nucleus. Unlike in the wild type,
however, Snf1-GFP failed to enrich in the nucleus of rho0 cells after shift to ethanol-glycerol
(Fig. 26C). Since nuclear enrichment of Snf1 is completely dependent on Gal83 (VINCENT et al.
2001), we also examined the nuclear localization of Gal83-GFP. Surprisingly, Gal83-GFP
showed normal nuclear enrichment in the rho0 mutant (Fig. 26D, bottom panel). This implied
that in rho0 cells, Gal83 is not associated with Snf1.
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0

Fig. 26. Effects of respiratory deficiency on the localization of Snf1 and Gal83. The rho mutation affects nuclear
enrichment of Snf1, but not of Gal83. (A, C) Wild-type and rho0 cells expressing Snf1-GFP from plasmid pSnf1GFP were grown to mid-log phase in selective SC medium containing abundant (2%) glucose (Glu) and shifted for
20 min to an otherwise identical medium containing 3% ethanol and 2% glycerol as the carbon source (EG). Nuclei
were stained with DAPI, and localization of Snf1-GFP was determined by fluorescence microscopy. (B,D) Wildtype and rho0 cells expressed Gal83-GFP from plasmid pRT12, and experiments were performed as for panels A and
C. (E) Cells were grown as for panels A and C, and Thr210 phosphorylation (PT210) and total Snf1-GFP protein
levels were detected by immunoblotting using anti-phospho-Thr172-AMPK and anti-GFP, respectively. (F) Cells
were grown as for panels B and D, and Gal83-GFP protein levels (Gal83-GFP), as well as Thr210 phosphorylation
(PT210) and total levels of Snf1 (Total) were analyzed by immunoblotting using anti-GFP, anti-phospho-Thr172AMPK, and anti-polyhistidine antibodies, respectively.
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Deletion of the SIP2 gene restores nuclear enrichment of Snf1 in rho0 cells.
The three alternative β subunits bind to the catalytic α subunit Snf1 in a competitive
manner via their conserved C-terminal domains (HEDBACKER AND CARLSON 2008). The
observation that Gal83-GFP localizes to the nucleus of rho0 cells, but Snf1-GFP does not,
indicated that Gal83 is not associated with Snf1 and suggested that Snf1 is predominantly bound
to another β subunit(s). If so, elimination of the β subunit(s) responsible for this effect could
restore the association of Gal83 and Snf1 and thereby restore Snf1 nuclear localization. To test
this hypothesis, we constructed rho0 sip1∆ and rho0 sip2∆ mutants and examined Snf1-GFP
localization as above. Snf1-GFP failed to enrich in the nucleus in the rho0 sip1∆ mutant (Fig.
27A). In the rho0 sip2∆ mutant, however, the nuclear enrichment of Snf1-GFP was restored (Fig.
27B). In both mutants, Snf1-GFP was expressed and phosphorylated on Thr210 at similar levels
(Fig. 27C).
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Fig. 27. Roles of the β subunits in Snf1 localization in respiratory-deficient cells. Absence of Sip2, but not of Sip1,
from rho0 cells restores nuclear enrichment of Snf1. Localization of Snf1-GFP was determined by fluorescence
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microscopy in (A) rho0 sip1∆ and (B) rho0 sip2∆ cells after growth in SC-Ura in the presence of 2% glucose (Glu),
and upon a 20 min shift to an otherwise identical medium containing a mixture of 3% ethanol and 2% glycerol as the
carbon source (EG). Nuclei were stained with DAPI. (C) Thr210 phosphorylation (PT210) and total Snf1-GFP
protein levels were detected by using anti-phospho-Thr172-AMPK and anti-GFP, respectively.

The rho0 mutation leads to increased expression of Sip2.
A simple explanation for why deletion of SIP2 in rho0 cells restored the nuclear
localization of Snf1 could be that Sip2 levels are higher in the rho0 mutant than in the wild type,
making Snf1-Sip2 the major complex in rho0 cells. To test this, we expressed GFP-tagged Sip2
from its own promoter in wild-type and rho0 cells, and examined Sip2-GFP levels by
immunoblotting using anti-GFP. In comparison to wild-type cells, Sip2-GFP expression was
substantially higher in rho0 cells both in abundant glucose and in ethanol-glycerol (Fig. 28).
Collectively, these results suggest that Sip2 is expressed at a much higher level in rho0
cells and outcompetes Gal83 for Snf1 binding, thus causing cytoplasmic retention of the kinase.
Vec
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Fig. 28. Effect of respiratory deficiency on Sip2 β subunit expression. Cells of the indicated genotypes transformed
with low-copy CEN-URA3 vector pRS316 (Vec) or its derivative plasmid pTM2 expressing Sip2-GFP from the
native SIP2 promoter were grown in selective SC medium containing 2% glucose (G) and then shifted for 20 min to
an otherwise identical medium containing 3% ethanol and 2% glycerol as the carbon source (EG). The levels of
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Sip2-GFP were analyzed by immunoblotting using anti-GFP. Thr210 phosphorylation of Snf1 (PT210) and total
Snf1 protein levels (Total) were detected using anti-phospho-Thr172-AMPK antibody and anti-polyhistidine
antibody, respectively.

Discussion
The three alternative β subunits, Sip1, Sip2, and Gal83, function not only to hold the
heterotrimeric Snf1 protein complex together by binding to the catalytic α subunit and the
stimulatory γ subunit Snf4, but also play distinct roles in subcellular localization of the complex
and its substrate specificity (VINCENT AND CARLSON 1999; SCHMIDT AND MCCARTNEY 2000;
VINCENT et al. 2001; NATH et al. 2002). In the presence of abundant glucose, all three Snf1
isoforms are cytoplasmic; during glucose limitation or growth on non-fermentable carbon
sources, Snf1-Sip1 localizes to the vacuolar membrane, Snf1-Sip2 remains cytoplasmic, and
Gal83 directs Snf1 to the nucleus (VINCENT et al. 2001). The Snf1-Gal83 complex is the major
isoform of the kinase; it is responsible for nuclear Snf1 activity and contributes to transcriptional
activation of many glucose-repressible genes, including those involved in utilization of
alternative carbon sources, gluconeogenesis, and respiration (VINCENT AND CARLSON 1999;
SCHMIDT AND MCCARTNEY 2000; VINCENT et al. 2001; NATH et al. 2002; YOUNG et al. 2003).
The mechanisms that regulate the nuclear localization of Snf1 are not completely understood.
Our results have revealed a novel mechanism of nucleo-cytoplasmic distribution of Snf1.
Using a Snf1-GFP fusion protein, we show that respiratory-deficient yeast cells lacking the
mitochondrial genome (rho0) exhibit a Snf1 nuclear localization defect. Interestingly,
experiments with a Gal83-GFP fusion protein indicated that rho0 cells have no defect in Gal83
nuclear localization, suggesting that Snf1 and Gal83 are not associated together. We
hypothesized that most or all Snf1 is associated with another β subunit. We present evidence that
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this other β subunit is Sip2. First, deletion of the SIP2 gene restored normal Snf1 nuclear
localization in rho0 cells. Second, rho0 cells express Sip2 at a substantially higher level than
respiratory-proficient wild-type cells. We propose a model in which respiratory deficiency boosts
Sip2 expression and causes a redistribution of Snf1 isoforms in favor of the cytoplasmic Snf1Sip2 complex at the exclusion of the nuclear Snf1-Gal83 complex.
Respiration-deficient cells lacking the mitochondrial genome activate the so-called
retrograde pathway, which regulates nuclear gene expression to compensate for the loss of
mitochondrial function (LIU AND BUTOW 2006). The downstream effectors of this pathway are
Rtg1 and Rtg3, which form a heterodimeric transcriptional activator that recognizes a consensus
sequence GTGAC, also known as the R box, in the promoters of target genes ((LIU AND BUTOW
2006). Sequence analysis of the SIP2 promoter indicates the presence of at least six putative R
boxes. Further experiments will be required to address the functional significance of these boxes
and the role of the retrograde pathway in SIP2 regulation.
In yeast, respiration-deficient mitochondrial mutants occur spontaneously at a high
frequency (so-called petite mutants). The biological significance of this phenomenon remains a
matter of debate, but its existence clearly suggests an evolutionary advantage. Since such
mutants have reduced intracellular energy levels, it might be advantageous to prevent Snf1 from
entering the nucleus to reduce the expression of genes involved in the utilization of nonfermentable carbon sources and respiration if the mitochondrial respiratory function is entirely
unavailable in the first place. In addition, it is also possible that in respiration-deficient cells
important targets of Snf1 are predominantly present in the cytoplasm.
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In conclusion, this study expands the repertoire of novel mechanisms by which
mitochondria regulate the Snf1 protein kinase in yeast. Due to the evolutionary conservation of
Snf1/AMPK, similar mechanisms might exist in other eukaryotes.

Table 4. S. cerevisiae strains
Strain

4

Genotype

Source

CTY 10-5d

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1

R. Sternglanz

ANY1

MATa gal4 gal80 URA3::lexAop-lacZ his3 leu2 ade2 trp1
rho0

This study

MMY35

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This laboratory

AMS-R0

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1 rho0

This laboratory

AMS207

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

sip1Δ::KanMX6 rho0
AMS209

MATa his3–11,15 leu2–3,112 trp1–1 ura3–1

This study

sip2Δ::KanMX6 rho0
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Teaching Experience at UWM
•

Lab in Experimental Microbiology (BIO SCI 580), 2016-2017

•

Genetics Discussion (BIO SCI 325), 2016-2017

•

Lab in Cell Biology and Genetics (BIO SCI 316), 2013-2015

•

Lab in Anatomy and Physiology II (BIO SCI 203), 2011-2012

•

Lab in Foundations of Biological Sciences I (BIO SCI 150), 2015

•

Mentored and trained six undergraduate students and two graduate students in independent research.

Scholarships and Awards
•

Ruth Walker Graduate Grant-in-Aid Award, Spring 2015 and Spring 2016, UWM

•

Chancellor’s Award, granted each semester since Fall 2011, UWM

•

Best Graduate Talk Award (Cell and Molecular Biology), May 2015, UWM

•

Graduate Student Travel Award, September 2014, UWM

•

Junior Research Fellowship, Govt. of India, 2010

Volunteer Work
•

Co-coordinated the Biological Sciences Research Symposium, April 2016, UWM

•

Worked as market research analyst, Fall 2015, UWM Research Foundation (UWMRF)

•

Judged posters at the UW System Symposium for Undergraduate Research, Spring 2014 and 2015
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